[G03CA57, estrogens, conjugated (USP), The metabolism of Conjugated estrogens can be decreased when combined with Resveratrol.]
[G03CA57, estrogens, conjugated (USP), The metabolism of Antipyrine can be decreased when combined with Conjugated estrogens.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may decrease the anticoagulant activities of Antithrombin Alfa.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may decrease the anticoagulant activities of Antithrombin III human.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may decrease the anticoagulant activities of Streptokinase.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may decrease the excretion rate of Streptomycin which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may increase the thrombogenic activities of Antithymocyte immunoglobulin (rabbit).]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may decrease the excretion rate of Sucralfate which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may decrease the excretion rate of Sulbactam which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may decrease the excretion rate of Sulfadiazine which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may decrease the excretion rate of Sulfamethoxazole which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), Sulindac may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), The therapeutic efficacy of Glibornuride can be decreased when used in combination with Conjugated estrogens.]
[G03CA57, estrogens, conjugated (USP), Azapropazone may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), The excretion of Mercaptopurine can be decreased when combined with Conjugated estrogens.]
[G03CA57, estrogens, conjugated (USP), The excretion of Mercaptopurine can be decreased when combined with Conjugated estrogens.]
[G03CA57, estrogens, conjugated (USP), The metabolism of Tacrine can be decreased when combined with Conjugated estrogens.]
[G03CA57, estrogens, conjugated (USP), The metabolism of Tamoxifen can be decreased when combined with Conjugated estrogens.]
[G03CA57, estrogens, conjugated (USP), Temazepam may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may decrease the excretion rate of Terbutaline which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may decrease the anticoagulant activities of Dabigatran etexilate.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may decrease the excretion rate of Testolactone which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), The metabolism of Conjugated estrogens can be decreased when combined with Testosterone propionate.]
[G03CA57, estrogens, conjugated (USP), The excretion of Conjugated estrogens can be increased when combined with Testosterone.]
[G03CA57, estrogens, conjugated (USP), The excretion of Conjugated estrogens can be increased when combined with Testosterone enanthate.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may decrease the excretion rate of Testosterone undecanoate which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), The excretion of Tetracycline can be decreased when combined with Conjugated estrogens.]
[G03CA57, estrogens, conjugated (USP), Ceftaroline fosamil may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), Ceftaroline fosamil may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), The metabolism of Conjugated estrogens can be decreased when combined with Dronabinol.]
[G03CA57, estrogens, conjugated (USP), The excretion of Ellagic acid can be decreased when combined with Conjugated estrogens.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may increase the thrombogenic activities of Thalidomide.]
[G03CA57, estrogens, conjugated (USP), Theobromine may increase the excretion rate of Conjugated estrogens which could result in a lower serum level and potentially a reduction in efficacy.]
[G03CA57, estrogens, conjugated (USP), The metabolism of Theophylline can be decreased when combined with Conjugated estrogens.]
[G03CA57, estrogens, conjugated (USP), The metabolism of Conjugated estrogens can be decreased when combined with Thiabendazole.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may decrease the excretion rate of Thiethylperazine which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), The metabolism of Thiothixene can be decreased when combined with Conjugated estrogens.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may decrease the excretion rate of Moxisylyte which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), The therapeutic efficacy of Levothyroxine can be decreased when used in combination with Conjugated estrogens.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may decrease the excretion rate of Tiapride which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), The metabolism of Conjugated estrogens can be decreased when combined with Ticlopidine.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may decrease the excretion rate of Timolol which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may decrease the excretion rate of Timolol which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may decrease the excretion rate of Tinidazole which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may decrease the excretion rate of Tobramycin which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), The therapeutic efficacy of Tolazamide can be decreased when used in combination with Conjugated estrogens.]
[G03CA57, estrogens, conjugated (USP), The therapeutic efficacy of Tolbutamide can be decreased when used in combination with Conjugated estrogens.]
[G03CA57, estrogens, conjugated (USP), Tolmetin may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), Tramadol may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), The serum concentration of Triamcinolone can be increased when it is combined with Conjugated estrogens.]
[G03CA57, estrogens, conjugated (USP), Triamterene may increase the excretion rate of Conjugated estrogens which could result in a lower serum level and potentially a reduction in efficacy.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may decrease the excretion rate of Triazolam which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), Trichlormethiazide may increase the excretion rate of Conjugated estrogens which could result in a lower serum level and potentially a reduction in efficacy.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may decrease the excretion rate of Triethylenetetramine which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), The metabolism of Trifluoperazine can be decreased when combined with Conjugated estrogens.]
[G03CA57, estrogens, conjugated (USP), The excretion of Trifluridine can be decreased when combined with Conjugated estrogens.]
[G03CA57, estrogens, conjugated (USP), The therapeutic efficacy of Liothyronine can be decreased when used in combination with Conjugated estrogens.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may decrease the excretion rate of Trimebutine which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may decrease the excretion rate of Trimethoprim which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), The serum concentration of Trimipramine can be increased when it is combined with Conjugated estrogens.]
[G03CA57, estrogens, conjugated (USP), The metabolism of Conjugated estrogens can be decreased when combined with Troleandomycin.]
[G03CA57, estrogens, conjugated (USP), The risk or severity of angioedema can be increased when Conjugated estrogens is combined with Azilsartan medoxomil.]
[G03CA57, estrogens, conjugated (USP), The risk or severity of angioedema can be increased when Conjugated estrogens is combined with Azilsartan medoxomil.]
[G03CA57, estrogens, conjugated (USP), The serum concentration of Roflumilast can be increased when it is combined with Conjugated estrogens.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may increase the thrombogenic activities of Belimumab.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may increase the thrombogenic activities of Ipilimumab.]
[G03CA57, estrogens, conjugated (USP), Vandetanib may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may decrease the excretion rate of Oxyquinoline which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), The serum concentration of Conjugated estrogens can be increased when it is combined with Abiraterone.]
[G03CA57, estrogens, conjugated (USP), The metabolism of Conjugated estrogens can be decreased when combined with Linagliptin.]
[G03CA57, estrogens, conjugated (USP), The metabolism of Conjugated estrogens can be decreased when combined with Boceprevir.]
[G03CA57, estrogens, conjugated (USP), The metabolism of Conjugated estrogens can be decreased when combined with Telaprevir.]
[G03CA57, estrogens, conjugated (USP), Rilpivirine may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may decrease the anticoagulant activities of Urokinase.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may decrease the excretion rate of Vancomycin which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may decrease the excretion rate of Ezogabine which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may decrease the anticoagulant activities of Rivaroxaban.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may decrease the anticoagulant activities of Ticagrelor.]
[G03CA57, estrogens, conjugated (USP), The metabolism of Conjugated estrogens can be decreased when combined with Verapamil.]
[G03CA57, estrogens, conjugated (USP), The metabolism of Conjugated estrogens can be decreased when combined with Viloxazine.]
[G03CA57, estrogens, conjugated (USP), The excretion of Conjugated estrogens can be decreased when combined with Vinblastine.]
[G03CA57, estrogens, conjugated (USP), The excretion of Conjugated estrogens can be decreased when combined with Vincristine.]
[G03CA57, estrogens, conjugated (USP), Cyanocobalamin may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may decrease the excretion rate of Phylloquinone which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), The metabolism of Warfarin can be decreased when combined with Conjugated estrogens.]
[G03CA57, estrogens, conjugated (USP), The metabolism of Conjugated estrogens can be decreased when combined with Fusidic acid.]
[G03CA57, estrogens, conjugated (USP), Xipamide may increase the excretion rate of Conjugated estrogens which could result in a lower serum level and potentially a reduction in efficacy.]
[G03CA57, estrogens, conjugated (USP), The excretion of Zidovudine can be decreased when combined with Conjugated estrogens.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may decrease the anticoagulant activities of Sodium citrate.]
[G03CA57, estrogens, conjugated (USP), The metabolism of Conjugated estrogens can be decreased when combined with Indinavir.]
[G03CA57, estrogens, conjugated (USP), The metabolism of Conjugated estrogens can be decreased when combined with Indinavir.]
[G03CA57, estrogens, conjugated (USP), The serum concentration of Conjugated estrogens can be increased when it is combined with Vemurafenib.]
[G03CA57, estrogens, conjugated (USP), Pamidronic acid may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), Pamidronic acid may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may increase the thrombogenic activities of Brentuximab vedotin.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may decrease the excretion rate of Tiludronic acid which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), The risk or severity of angioedema can be increased when Conjugated estrogens is combined with Icatibant.]
[G03CA57, estrogens, conjugated (USP), The metabolism of Conjugated estrogens can be decreased when combined with Crizotinib.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may decrease the anticoagulant activities of Lepirudin.]
[G03CA57, estrogens, conjugated (USP), Rabeprazole may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), The serum concentration of Ascorbic acid can be decreased when it is combined with Conjugated estrogens.]
[G03CA57, estrogens, conjugated (USP), The metabolism of Conjugated estrogens can be decreased when combined with Trovafloxacin.]
[G03CA57, estrogens, conjugated (USP), The metabolism of Conjugated estrogens can be decreased when combined with Ziprasidone.]
[G03CA57, estrogens, conjugated (USP), Drospirenone may increase the excretion rate of Conjugated estrogens which could result in a lower serum level and potentially a reduction in efficacy.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may decrease the excretion rate of Deferiprone which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may increase the thrombogenic activities of Alemtuzumab.]
[G03CA57, estrogens, conjugated (USP), The excretion of Tenofovir can be decreased when combined with Conjugated estrogens.]
[G03CA57, estrogens, conjugated (USP), The excretion of Tenofovir can be decreased when combined with Conjugated estrogens.]
[G03CA57, estrogens, conjugated (USP), The excretion of Conjugated estrogens can be decreased when combined with Acetylsalicylic acid.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may decrease the excretion rate of Ruxolitinib which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may decrease the excretion rate of Tolterodine which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), The excretion of Doripenem can be decreased when combined with Conjugated estrogens.]
[G03CA57, estrogens, conjugated (USP), The metabolism of Conjugated estrogens can be decreased when combined with Peginterferon alfa-2a.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may increase the thrombogenic activities of Rituximab.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may increase the thrombogenic activities of Rituximab.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may increase the thrombogenic activities of Rituximab.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may increase the thrombogenic activities of Rituximab.]
[G03CA57, estrogens, conjugated (USP), The metabolism of Conjugated estrogens can be decreased when combined with Voriconazole.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may decrease the excretion rate of Auranofin which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may decrease the excretion rate of Tocopherol which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), Vismodegib may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), The metabolism of Axitinib can be decreased when combined with Conjugated estrogens.]
[G03CA57, estrogens, conjugated (USP), The serum concentration of Prednylidene can be increased when it is combined with Conjugated estrogens.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may decrease the excretion rate of Peginesatide which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), Robenacoxib may increase the thrombogenic activities of Conjugated estrogens.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may decrease the excretion rate of Azacitidine which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), The metabolism of Azathioprine can be decreased when combined with Conjugated estrogens.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may decrease the excretion rate of Gemcitabine which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may decrease the excretion rate of Aztreonam which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), Bacitracin may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), Bacitracin may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), The serum concentration of Avanafil can be increased when it is combined with Conjugated estrogens.]
[G03CA57, estrogens, conjugated (USP), Baclofen may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may increase the thrombogenic activities of Gemtuzumab ozogamicin.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may increase the thrombogenic activities of Pertuzumab.]
[G03CA57, estrogens, conjugated (USP), The metabolism of Lorcaserin can be decreased when combined with Conjugated estrogens.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may decrease the excretion rate of Mirabegron which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may decrease the excretion rate of Aclidinium which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may decrease the excretion rate of Bicisate which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), The metabolism of Conjugated estrogens can be decreased when combined with Cobicistat.]
[G03CA57, estrogens, conjugated (USP), The metabolism of Conjugated estrogens can be decreased when combined with Elvitegravir.]
[G03CA57, estrogens, conjugated (USP), The serum concentration of Conjugated estrogens can be decreased when it is combined with Enzalutamide.]
[G03CA57, estrogens, conjugated (USP), The metabolism of Conjugated estrogens can be increased when combined with St. John's Wort.]
[G03CA57, estrogens, conjugated (USP), The serum concentration of Conjugated estrogens can be decreased when it is combined with Teriflunomide.]
[G03CA57, estrogens, conjugated (USP), The metabolism of Xanthine can be decreased when combined with Conjugated estrogens.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may decrease the anticoagulant activities of Defibrotide.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may decrease the excretion rate of Chromium gluconate which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), The excretion of Conjugated estrogens can be decreased when combined with Aspartame.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may decrease the excretion rate of DL-Methylephedrine which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may decrease the excretion rate of DL-Methylephedrine which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), The serum concentration of Aldosterone can be increased when it is combined with Conjugated estrogens.]
[G03CA57, estrogens, conjugated (USP), Regorafenib may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), Hesperetin may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), The excretion of Cyclic adenosine monophosphate can be decreased when combined with Conjugated estrogens.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may increase the thrombogenic activities of Fanolesomab.]
[G03CA57, estrogens, conjugated (USP), Potassium cation may increase the excretion rate of Conjugated estrogens which could result in a lower serum level and potentially a reduction in efficacy.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may decrease the excretion rate of Octinoxate which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), The metabolism of Conjugated estrogens can be decreased when combined with Nelfinavir.]
[G03CA57, estrogens, conjugated (USP), The metabolism of Bendamustine can be decreased when combined with Conjugated estrogens.]
[G03CA57, estrogens, conjugated (USP), Beclomethasone dipropionate may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), The metabolism of Rasagiline can be decreased when combined with Conjugated estrogens.]
[G03CA57, estrogens, conjugated (USP), The metabolism of Perampanel can be decreased when combined with Conjugated estrogens.]
[G03CA57, estrogens, conjugated (USP), The metabolism of Zolmitriptan can be decreased when combined with Conjugated estrogens.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may decrease the excretion rate of Fludeoxyglucose (18F) which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may increase the thrombogenic activities of Capromab pendetide.]
[G03CA57, estrogens, conjugated (USP), The serum concentration of Niacinamide ascorbate can be decreased when it is combined with Conjugated estrogens.]
[G03CA57, estrogens, conjugated (USP), The excretion of Conjugated estrogens can be decreased when combined with Sildenafil.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may decrease the excretion rate of Gadofosveset trisodium which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may decrease the excretion rate of Gadofosveset trisodium which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), Ponatinib may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may decrease the anticoagulant activities of Apixaban.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may decrease the excretion rate of Teduglutide which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may increase the thrombogenic activities of Raxibacumab.]
[G03CA57, estrogens, conjugated (USP), The risk or severity of angioedema can be increased when Conjugated estrogens is combined with Alogliptin.]
[G03CA57, estrogens, conjugated (USP), Naringenin may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may decrease the excretion rate of Glycerol phenylbutyrate which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may decrease the anticoagulant activities of Ferulic acid.]
[G03CA57, estrogens, conjugated (USP), Bendroflumethiazide may increase the excretion rate of Conjugated estrogens which could result in a lower serum level and potentially a reduction in efficacy.]
[G03CA57, estrogens, conjugated (USP), The metabolism of Pomalidomide can be decreased when combined with Conjugated estrogens.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may decrease the excretion rate of Tetradecyl hydrogen sulfate (ester) which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), The serum concentration of Ascorbic acid can be decreased when it is combined with Conjugated estrogens.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may decrease the anticoagulant activities of Edetic acid.]
[G03CA57, estrogens, conjugated (USP), The risk or severity of adverse effects can be increased when Conjugated estrogens is combined with Ospemifene.]
[G03CA57, estrogens, conjugated (USP), Benorilate may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), Canagliflozin may increase the excretion rate of Conjugated estrogens which could result in a lower serum level and potentially a reduction in efficacy.]
[G03CA57, estrogens, conjugated (USP), Canagliflozin may increase the excretion rate of Conjugated estrogens which could result in a lower serum level and potentially a reduction in efficacy.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may decrease the excretion rate of Benserazide which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may decrease the anticoagulant activities of Tocopherylquinone.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may decrease the excretion rate of Chromium nicotinate which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), The metabolism of Conjugated estrogens can be decreased when combined with Gemifloxacin.]
[G03CA57, estrogens, conjugated (USP), The excretion of Conjugated estrogens can be decreased when combined with Benzbromarone.]
[G03CA57, estrogens, conjugated (USP), The metabolism of Conjugated estrogens can be decreased when combined with Moxifloxacin.]
[G03CA57, estrogens, conjugated (USP), The metabolism of Conjugated estrogens can be decreased when combined with Tegaserod.]
[G03CA57, estrogens, conjugated (USP), The therapeutic efficacy of Tiratricol can be decreased when used in combination with Conjugated estrogens.]
[G03CA57, estrogens, conjugated (USP), The therapeutic efficacy of Insulin detemir can be decreased when used in combination with Conjugated estrogens.]
[G03CA57, estrogens, conjugated (USP), The metabolism of Benzocaine can be decreased when combined with Conjugated estrogens.]
[G03CA57, estrogens, conjugated (USP), The excretion of Caspofungin can be decreased when combined with Conjugated estrogens.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may decrease the excretion rate of Ancestim which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), Celecoxib may increase the thrombogenic activities of Conjugated estrogens.]
[G03CA57, estrogens, conjugated (USP), The excretion of Conjugated estrogens can be decreased when combined with Everolimus.]
[G03CA57, estrogens, conjugated (USP), Benzatropine may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), The serum concentration of Calcium ascorbate can be decreased when it is combined with Conjugated estrogens.]
[G03CA57, estrogens, conjugated (USP), The serum concentration of Calcium ascorbate can be decreased when it is combined with Conjugated estrogens.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may decrease the excretion rate of Vilanterol which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), The serum concentration of Conjugated estrogens can be decreased when it is combined with Dabrafenib.]
[G03CA57, estrogens, conjugated (USP), Benzydamine may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may decrease the excretion rate of Trametinib which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), The metabolism of Benzyl alcohol can be decreased when combined with Conjugated estrogens.]
[G03CA57, estrogens, conjugated (USP), Hygromycin B may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may decrease the excretion rate of Indigotindisulfonic acid which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), The excretion of Oxalic Acid can be decreased when combined with Conjugated estrogens.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may decrease the excretion rate of Florbetapir (18F) which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), Afatinib may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may increase the thrombogenic activities of Dalotuzumab.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may decrease the excretion rate of Levomilnacipran which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), The excretion of Conjugated estrogens can be decreased when combined with Dolutegravir.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may decrease the excretion rate of Evening primrose oil which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may decrease the excretion rate of Lixisenatide which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), The excretion of Cholic Acid can be decreased when combined with Conjugated estrogens.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may decrease the excretion rate of Macitentan which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may decrease the excretion rate of Iobenguane sulfate I-123 which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may decrease the excretion rate of Vortioxetine which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may decrease the excretion rate of Etonogestrel which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), The metabolism of Conjugated estrogens can be decreased when combined with Simeprevir.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may decrease the excretion rate of Sofosbuvir which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), Dapagliflozin may increase the excretion rate of Conjugated estrogens which could result in a lower serum level and potentially a reduction in efficacy.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may decrease the excretion rate of Droxidopa which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), The metabolism of Tasimelteon can be decreased when combined with Conjugated estrogens.]
[G03CA57, estrogens, conjugated (USP), The metabolism of Conjugated estrogens can be increased when combined with Metreleptin.]
[G03CA57, estrogens, conjugated (USP), The metabolism of Conjugated estrogens can be increased when combined with Apremilast.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may decrease the excretion rate of Formestane which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), The serum concentration of Betamethasone can be increased when it is combined with Conjugated estrogens.]
[G03CA57, estrogens, conjugated (USP), The metabolism of Conjugated estrogens can be decreased when combined with Betaxolol.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may decrease the anticoagulant activities of Argatroban.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may decrease the anticoagulant activities of Argatroban.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may decrease the excretion rate of Fomepizole which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), The excretion of Conjugated estrogens can be decreased when combined with Bezafibrate.]
[G03CA57, estrogens, conjugated (USP), The metabolism of Conjugated estrogens can be increased when combined with Siltuximab.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may increase the thrombogenic activities of Ramucirumab.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may increase the thrombogenic activities of Eftrenonacog alfa.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may decrease the anticoagulant activities of Vorapaxar.]
[G03CA57, estrogens, conjugated (USP), The serum concentration of Melengestrol can be increased when it is combined with Conjugated estrogens.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may increase the thrombogenic activities of Vedolizumab.]
[G03CA57, estrogens, conjugated (USP), The metabolism of Acenocoumarol can be decreased when combined with Conjugated estrogens.]
[G03CA57, estrogens, conjugated (USP), The metabolism of Conjugated estrogens can be increased when combined with Belinostat.]
[G03CA57, estrogens, conjugated (USP), The excretion of Conjugated estrogens can be decreased when combined with Idelalisib.]
[G03CA57, estrogens, conjugated (USP), The serum concentration of Conjugated estrogens can be increased when it is combined with Tafamidis.]
[G03CA57, estrogens, conjugated (USP), Diatrizoate may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), Lithium cation may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may decrease the anticoagulant activities of Dabigatran.]
[G03CA57, estrogens, conjugated (USP), The risk or severity of angioedema can be increased when Conjugated estrogens is combined with Moexiprilat.]
[G03CA57, estrogens, conjugated (USP), The risk or severity of angioedema can be increased when Conjugated estrogens is combined with Quinaprilat.]
[G03CA57, estrogens, conjugated (USP), The risk or severity of angioedema can be increased when Conjugated estrogens is combined with Ramiprilat.]
[G03CA57, estrogens, conjugated (USP), The risk or severity of angioedema can be increased when Conjugated estrogens is combined with Trandolaprilat.]
[G03CA57, estrogens, conjugated (USP), Bromotheophylline may increase the excretion rate of Conjugated estrogens which could result in a lower serum level and potentially a reduction in efficacy.]
[G03CA57, estrogens, conjugated (USP), The risk or severity of angioedema can be increased when Conjugated estrogens is combined with Fosinoprilat.]
[G03CA57, estrogens, conjugated (USP), The risk or severity of angioedema can be increased when Conjugated estrogens is combined with Perindoprilat.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may decrease the excretion rate of Gadopentetic acid which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), Diatrizoate may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may decrease the excretion rate of Isosulfan blue which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may decrease the excretion rate of Picosulfuric acid which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may increase the thrombogenic activities of Pembrolizumab.]
[G03CA57, estrogens, conjugated (USP), The serum concentration of Zinc ascorbate can be decreased when it is combined with Conjugated estrogens.]
[G03CA57, estrogens, conjugated (USP), Dihydrostreptomycin may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may decrease the anticoagulant activities of Pentosan polysulfate.]
[G03CA57, estrogens, conjugated (USP), The excretion of Silibinin can be decreased when combined with Conjugated estrogens.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may increase the thrombogenic activities of Dulaglutide.]
[G03CA57, estrogens, conjugated (USP), The metabolism of Conjugated estrogens can be decreased when combined with Netupitant.]
[G03CA57, estrogens, conjugated (USP), The metabolism of Conjugated estrogens can be decreased when combined with Fosnetupitant.]
[G03CA57, estrogens, conjugated (USP), Ledipasvir may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), The metabolism of Pirfenidone can be decreased when combined with Conjugated estrogens.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may decrease the excretion rate of Gentamicin which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may increase the thrombogenic activities of Blinatumomab.]
[G03CA57, estrogens, conjugated (USP), The risk or severity of liver enzyme elevations can be increased when Conjugated estrogens is combined with Ombitasvir.]
[G03CA57, estrogens, conjugated (USP), The risk or severity of liver enzyme elevations can be increased when Conjugated estrogens is combined with Paritaprevir.]
[G03CA57, estrogens, conjugated (USP), The risk or severity of liver enzyme elevations can be increased when Conjugated estrogens is combined with Dasabuvir.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may decrease the excretion rate of Ceftolozane which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may increase the thrombogenic activities of Nivolumab.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may decrease the anticoagulant activities of Dicoumarol.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may decrease the anticoagulant activities of Edoxaban.]
[G03CA57, estrogens, conjugated (USP), The metabolism of Mirtazapine can be decreased when combined with Conjugated estrogens.]
[G03CA57, estrogens, conjugated (USP), The metabolism of Conjugated estrogens can be increased when combined with Secukinumab.]
[G03CA57, estrogens, conjugated (USP), Palbociclib may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), The excretion of Conjugated estrogens can be decreased when combined with Lenvatinib.]
[G03CA57, estrogens, conjugated (USP), The excretion of Avibactam can be decreased when combined with Conjugated estrogens.]
[G03CA57, estrogens, conjugated (USP), Daclatasvir may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may increase the thrombogenic activities of Dinutuximab.]
[G03CA57, estrogens, conjugated (USP), The metabolism of Conjugated estrogens can be decreased when combined with Isavuconazonium.]
[G03CA57, estrogens, conjugated (USP), The metabolism of Acetaminophen can be decreased when combined with Conjugated estrogens.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may decrease the excretion rate of Bleomycin which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may decrease the anticoagulant activities of Tioclomarol.]
[G03CA57, estrogens, conjugated (USP), Adefovir dipivoxil may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), Adefovir may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), The excretion of Asunaprevir can be decreased when combined with Conjugated estrogens.]
[G03CA57, estrogens, conjugated (USP), The serum concentration of Eluxadoline can be increased when it is combined with Conjugated estrogens.]
[G03CA57, estrogens, conjugated (USP), The metabolism of Conjugated estrogens can be increased when combined with Lumacaftor.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may decrease the anticoagulant activities of Cangrelor.]
[G03CA57, estrogens, conjugated (USP), The risk or severity of angioedema can be increased when Conjugated estrogens is combined with Sacubitril.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may increase the thrombogenic activities of Alirocumab.]
[G03CA57, estrogens, conjugated (USP), Rolapitant may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may increase the thrombogenic activities of Evolocumab.]
[G03CA57, estrogens, conjugated (USP), Aceclofenac may increase the thrombogenic activities of Conjugated estrogens.]
[G03CA57, estrogens, conjugated (USP), Acemetacin may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), Acetazolamide may increase the excretion rate of Conjugated estrogens which could result in a lower serum level and potentially a reduction in efficacy.]
[G03CA57, estrogens, conjugated (USP), The therapeutic efficacy of Insulin degludec can be decreased when used in combination with Conjugated estrogens.]
[G03CA57, estrogens, conjugated (USP), The excretion of Conjugated estrogens can be decreased when combined with Lansoprazole.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may increase the thrombogenic activities of Idarucizumab.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may increase the thrombogenic activities of Asfotase alfa.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may increase the thrombogenic activities of Mepolizumab.]
[G03CA57, estrogens, conjugated (USP), The metabolism of Conjugated estrogens can be decreased when combined with Isavuconazole.]
[G03CA57, estrogens, conjugated (USP), The serum concentration of Conjugated estrogens can be decreased when it is combined with Osimertinib.]
[G03CA57, estrogens, conjugated (USP), The serum concentration of Tenofovir alafenamide can be increased when it is combined with Conjugated estrogens.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may increase the thrombogenic activities of Daratumumab.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may increase the thrombogenic activities of Anthrax immune globulin human.]
[G03CA57, estrogens, conjugated (USP), The excretion of Conjugated estrogens can be decreased when combined with Cobimetinib.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may decrease the excretion rate of Ixazomib which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may increase the thrombogenic activities of Necitumumab.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may increase the thrombogenic activities of Elotuzumab.]
[G03CA57, estrogens, conjugated (USP), Alectinib may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may decrease the excretion rate of Kanamycin which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may increase the thrombogenic activities of Tetanus immune globulin, human.]
[G03CA57, estrogens, conjugated (USP), The excretion of Selexipag can be decreased when combined with Conjugated estrogens.]
[G03CA57, estrogens, conjugated (USP), The therapeutic efficacy of Acetohexamide can be decreased when used in combination with Conjugated estrogens.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may decrease the excretion rate of Lesinurad which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), Elbasvir may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), Grazoprevir may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), Grazoprevir may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), Alminoprofen may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may decrease the excretion rate of Brivaracetam which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), The therapeutic efficacy of Insulin argine can be decreased when used in combination with Conjugated estrogens.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may increase the thrombogenic activities of Ixekizumab.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may increase the thrombogenic activities of Reslizumab.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may increase the thrombogenic activities of Obiltoxaximab.]
[G03CA57, estrogens, conjugated (USP), The metabolism of Conjugated estrogens can be decreased when combined with Venetoclax.]
[G03CA57, estrogens, conjugated (USP), The metabolism of Bromazepam can be decreased when combined with Conjugated estrogens.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may decrease the excretion rate of Almasilate which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), The serum concentration of Amineptine can be increased when it is combined with Conjugated estrogens.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may increase the thrombogenic activities of Atezolizumab.]
[G03CA57, estrogens, conjugated (USP), The metabolism of Conjugated estrogens can be decreased when combined with Obeticholic acid.]
[G03CA57, estrogens, conjugated (USP), Velpatasvir may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), The excretion of Bumetanide can be decreased when combined with Conjugated estrogens.]
[G03CA57, estrogens, conjugated (USP), The metabolism of Levobupivacaine can be decreased when combined with Conjugated estrogens.]
[G03CA57, estrogens, conjugated (USP), Buprenorphine may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may decrease the excretion rate of Buspirone which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may decrease the excretion rate of Arsenic trioxide which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), Rabeprazole may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may decrease the anticoagulant activities of Astaxanthin.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may increase the thrombogenic activities of Bezlotoxumab.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may increase the thrombogenic activities of Olaratumab.]
[G03CA57, estrogens, conjugated (USP), The metabolism of Azelastine can be decreased when combined with Conjugated estrogens.]
[G03CA57, estrogens, conjugated (USP), Rucaparib may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), Azosemide may increase the excretion rate of Conjugated estrogens which could result in a lower serum level and potentially a reduction in efficacy.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may increase the thrombogenic activities of Brodalumab.]
[G03CA57, estrogens, conjugated (USP), The serum concentration of Conjugated estrogens can be decreased when it is combined with Telotristat ethyl.]
[G03CA57, estrogens, conjugated (USP), The metabolism of Conjugated estrogens can be decreased when combined with Ribociclib.]
[G03CA57, estrogens, conjugated (USP), Balsalazide may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), The metabolism of Bamifylline can be decreased when combined with Conjugated estrogens.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may increase the thrombogenic activities of Avelumab.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may increase the thrombogenic activities of Ocrelizumab.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may increase the thrombogenic activities of Dupilumab.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may decrease the excretion rate of Naldemedine which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may decrease the excretion rate of Deutetrabenazine which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), The risk or severity of angioedema can be increased when Pregabalin is combined with Conjugated estrogens.]
[G03CA57, estrogens, conjugated (USP), The metabolism of Conjugated estrogens can be decreased when combined with Caffeine.]
[G03CA57, estrogens, conjugated (USP), The risk or severity of angioedema can be increased when Conjugated estrogens is combined with Benazepril.]
[G03CA57, estrogens, conjugated (USP), The risk or severity of angioedema can be increased when Conjugated estrogens is combined with Benazeprilat.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may decrease the excretion rate of Benznidazole which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), Benzthiazide may increase the excretion rate of Conjugated estrogens which could result in a lower serum level and potentially a reduction in efficacy.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may increase the thrombogenic activities of Daclizumab.]
[G03CA57, estrogens, conjugated (USP), The excretion of Conjugated estrogens can be decreased when combined with Linezolid.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may decrease the excretion rate of Abacavir which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), The metabolism of Conjugated estrogens can be decreased when combined with Tipranavir.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may decrease the excretion rate of Valbenazine which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), The metabolism of Conjugated estrogens can be increased when combined with Infliximab.]
[G03CA57, estrogens, conjugated (USP), The metabolism of Conjugated estrogens can be increased when combined with Infliximab.]
[G03CA57, estrogens, conjugated (USP), The metabolism of Conjugated estrogens can be increased when combined with Infliximab.]
[G03CA57, estrogens, conjugated (USP), The metabolism of Conjugated estrogens can be increased when combined with Infliximab.]
[G03CA57, estrogens, conjugated (USP), The metabolism of Conjugated estrogens can be increased when combined with Infliximab.]
[G03CA57, estrogens, conjugated (USP), The metabolism of Conjugated estrogens can be decreased when combined with Midostaurin.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may increase the thrombogenic activities of Durvalumab.]
[G03CA57, estrogens, conjugated (USP), Brigatinib may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), Safinamide may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may increase the thrombogenic activities of Sarilumab.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may decrease the excretion rate of Delafloxacin which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may decrease the anticoagulant activities of Betrixaban.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may increase the thrombogenic activities of Guselkumab.]
[G03CA57, estrogens, conjugated (USP), Voxilaprevir may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may decrease the excretion rate of Capecitabine which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), The metabolism of Enasidenib can be decreased when combined with Conjugated estrogens.]
[G03CA57, estrogens, conjugated (USP), Glecaprevir may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), Pibrentasvir may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may increase the thrombogenic activities of Palivizumab.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may increase the thrombogenic activities of Inotuzumab ozogamicin.]
[G03CA57, estrogens, conjugated (USP), The excretion of Glutaric Acid can be decreased when combined with Conjugated estrogens.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may decrease the excretion rate of Vaborbactam which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), Abemaciclib may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may decrease the excretion rate of Bismuth subgallate which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may decrease the excretion rate of Bisoprolol which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), The metabolism of Conjugated estrogens can be decreased when combined with Efavirenz.]
[G03CA57, estrogens, conjugated (USP), The metabolism of Conjugated estrogens can be decreased when combined with Lopinavir.]
[G03CA57, estrogens, conjugated (USP), Cefprozil may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), Cefprozil may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may increase the thrombogenic activities of Basiliximab.]
[G03CA57, estrogens, conjugated (USP), The excretion of Conjugated estrogens can be decreased when combined with Acetylcysteine.]
[G03CA57, estrogens, conjugated (USP), The metabolism of Conjugated estrogens can be decreased when combined with Cannabinol.]
[G03CA57, estrogens, conjugated (USP), Canrenone may increase the excretion rate of Conjugated estrogens which could result in a lower serum level and potentially a reduction in efficacy.]
[G03CA57, estrogens, conjugated (USP), The serum concentration of Budesonide can be increased when it is combined with Conjugated estrogens.]
[G03CA57, estrogens, conjugated (USP), Bumadizone may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), Buthiazide may increase the excretion rate of Conjugated estrogens which could result in a lower serum level and potentially a reduction in efficacy.]
[G03CA57, estrogens, conjugated (USP), The excretion of Conjugated estrogens can be decreased when combined with Letermovir.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may increase the thrombogenic activities of Benralizumab.]
[G03CA57, estrogens, conjugated (USP), The serum concentration of Butriptyline can be increased when it is combined with Conjugated estrogens.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may increase the thrombogenic activities of Emicizumab.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may increase the thrombogenic activities of Emicizumab.]
[G03CA57, estrogens, conjugated (USP), The metabolism of Conjugated estrogens can be increased when combined with Capsaicin.]
[G03CA57, estrogens, conjugated (USP), Ertugliflozin may increase the excretion rate of Conjugated estrogens which could result in a lower serum level and potentially a reduction in efficacy.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may decrease the excretion rate of Acrivastine which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), The excretion of Captopril can be decreased when combined with Conjugated estrogens.]
[G03CA57, estrogens, conjugated (USP), The metabolism of Conjugated estrogens can be increased when combined with Apalutamide.]
[G03CA57, estrogens, conjugated (USP), The metabolism of Conjugated estrogens can be increased when combined with Carbamazepine.]
[G03CA57, estrogens, conjugated (USP), The excretion of Conjugated estrogens can be decreased when combined with Caprylic acid.]
[G03CA57, estrogens, conjugated (USP), Carbidopa may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), Carbidopa may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), The metabolism of Conjugated estrogens can be decreased when combined with Interferon alfa-n1.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may decrease the excretion rate of Evening primrose oil which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may increase the thrombogenic activities of Digoxin Immune Fab (Ovine).]
[G03CA57, estrogens, conjugated (USP), Carprofen may increase the thrombogenic activities of Conjugated estrogens.]
[G03CA57, estrogens, conjugated (USP), The metabolism of Carvedilol can be decreased when combined with Conjugated estrogens.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may increase the thrombogenic activities of Ibalizumab.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may increase the thrombogenic activities of Ibalizumab.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may increase the thrombogenic activities of Burosumab.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may increase the thrombogenic activities of Burosumab.]
[G03CA57, estrogens, conjugated (USP), Fostamatinib may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), Cannabidiol may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may increase the thrombogenic activities of Erenumab.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may increase the thrombogenic activities of Erenumab.]
[G03CA57, estrogens, conjugated (USP), The excretion of Conjugated estrogens can be decreased when combined with Avatrombopag.]
[G03CA57, estrogens, conjugated (USP), The serum concentration of Baricitinib can be increased when it is combined with Conjugated estrogens.]
[G03CA57, estrogens, conjugated (USP), Cefepime may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), Cefetamet may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), Cefodizime may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), Ceforanide may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), Cefpodoxime may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), The metabolism of Binimetinib can be decreased when combined with Conjugated estrogens.]
[G03CA57, estrogens, conjugated (USP), The excretion of Ceftibuten can be decreased when combined with Conjugated estrogens.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may decrease the excretion rate of Plazomicin which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), The excretion of Elagolix can be decreased when combined with Conjugated estrogens.]
[G03CA57, estrogens, conjugated (USP), The metabolism of Conjugated estrogens can be increased when combined with Ivosidenib.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may increase the thrombogenic activities of Tildrakizumab.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may increase the thrombogenic activities of Tildrakizumab.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may increase the thrombogenic activities of Mogamulizumab.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may increase the thrombogenic activities of Mogamulizumab.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may decrease the excretion rate of Migalastat which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), The metabolism of Conjugated estrogens can be decreased when combined with Stiripentol.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may increase the thrombogenic activities of Lanadelumab.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may increase the thrombogenic activities of Lanadelumab.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may decrease the excretion rate of Antihemophilic factor (recombinant), PEGylated which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may increase the thrombogenic activities of Fremanezumab.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may increase the thrombogenic activities of Cemiplimab.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may increase the thrombogenic activities of Cemiplimab.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may increase the thrombogenic activities of Galcanezumab.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may increase the thrombogenic activities of Galcanezumab.]
[G03CA57, estrogens, conjugated (USP), Dacomitinib may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), Dacomitinib may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may decrease the excretion rate of Cetirizine which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), The therapeutic efficacy of Carbutamide can be decreased when used in combination with Conjugated estrogens.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may decrease the excretion rate of Chloroxylenol which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), Lornoxicam may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), The metabolism of Oxtriphylline can be decreased when combined with Conjugated estrogens.]
[G03CA57, estrogens, conjugated (USP), Inotersen may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may decrease the excretion rate of Chromic chloride which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may decrease the excretion rate of Revefenacin which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), The metabolism of Conjugated estrogens can be increased when combined with Emapalumab.]
[G03CA57, estrogens, conjugated (USP), The metabolism of Conjugated estrogens can be increased when combined with Emapalumab.]
[G03CA57, estrogens, conjugated (USP), The metabolism of Conjugated estrogens can be decreased when combined with Carmustine.]
[G03CA57, estrogens, conjugated (USP), Gilteritinib may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), Glasdegib may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may increase the thrombogenic activities of Ravulizumab.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may increase the thrombogenic activities of Ravulizumab.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may decrease the excretion rate of Prucalopride which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), The risk or severity of angioedema can be increased when Conjugated estrogens is combined with Cilazapril.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may increase the thrombogenic activities of Caplacizumab.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may increase the thrombogenic activities of Caplacizumab.]
[G03CA57, estrogens, conjugated (USP), The metabolism of Cilostazol can be decreased when combined with Conjugated estrogens.]
[G03CA57, estrogens, conjugated (USP), The metabolism of Conjugated estrogens can be decreased when combined with Triclabendazole.]
[G03CA57, estrogens, conjugated (USP), The metabolism of Conjugated estrogens can be decreased when combined with Clarithromycin.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may decrease the excretion rate of Solriamfetol which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may increase the thrombogenic activities of Romosozumab.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may increase the thrombogenic activities of Romosozumab.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may decrease the excretion rate of Clobazam which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), The serum concentration of Cloprednol can be increased when it is combined with Conjugated estrogens.]
[G03CA57, estrogens, conjugated (USP), The excretion of Conjugated estrogens can be decreased when combined with Candesartan.]
[G03CA57, estrogens, conjugated (USP), The metabolism of Conjugated estrogens can be increased when combined with Etanercept.]
[G03CA57, estrogens, conjugated (USP), The metabolism of Conjugated estrogens can be increased when combined with Etanercept.]
[G03CA57, estrogens, conjugated (USP), The metabolism of Conjugated estrogens can be increased when combined with Etanercept.]
[G03CA57, estrogens, conjugated (USP), Choline magnesium trisalicylate may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), The metabolism of Ethanol can be decreased when combined with Conjugated estrogens.]
[G03CA57, estrogens, conjugated (USP), The serum concentration of Cortivazol can be increased when it is combined with Conjugated estrogens.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may increase the thrombogenic activities of Risankizumab.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may increase the thrombogenic activities of Risankizumab.]
[G03CA57, estrogens, conjugated (USP), The metabolism of Conjugated estrogens can be decreased when combined with Medical Cannabis.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may increase the thrombogenic activities of Polatuzumab vedotin.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may increase the thrombogenic activities of Polatuzumab vedotin.]
[G03CA57, estrogens, conjugated (USP), The excretion of Cefaclor can be decreased when combined with Conjugated estrogens.]
[G03CA57, estrogens, conjugated (USP), The excretion of Cefaclor can be decreased when combined with Conjugated estrogens.]
[G03CA57, estrogens, conjugated (USP), The excretion of Conjugated estrogens can be decreased when combined with Cefadroxil.]
[G03CA57, estrogens, conjugated (USP), The excretion of Conjugated estrogens can be decreased when combined with Cefadroxil.]
[G03CA57, estrogens, conjugated (USP), The excretion of Conjugated estrogens can be decreased when combined with Cefamandole.]
[G03CA57, estrogens, conjugated (USP), The excretion of Conjugated estrogens can be decreased when combined with Selinexor.]
[G03CA57, estrogens, conjugated (USP), Cefatrizine may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), The excretion of Cefazolin can be decreased when combined with Conjugated estrogens.]
[G03CA57, estrogens, conjugated (USP), The serum concentration of Conjugated estrogens can be increased when it is combined with Darolutamide.]
[G03CA57, estrogens, conjugated (USP), Cefmetazole may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), Cefonicid may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), The excretion of Conjugated estrogens can be decreased when combined with Pexidartinib.]
[G03CA57, estrogens, conjugated (USP), The excretion of Conjugated estrogens can be decreased when combined with Cefoperazone.]
[G03CA57, estrogens, conjugated (USP), The excretion of Relebactam can be decreased when combined with Conjugated estrogens.]
[G03CA57, estrogens, conjugated (USP), The excretion of Relebactam can be decreased when combined with Conjugated estrogens.]
[G03CA57, estrogens, conjugated (USP), The excretion of Conjugated estrogens can be decreased when combined with Cefotaxime.]
[G03CA57, estrogens, conjugated (USP), Cefotetan may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), The excretion of Conjugated estrogens can be decreased when combined with Cefotiam.]
[G03CA57, estrogens, conjugated (USP), Cefoxitin may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), Cefsulodin may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), Ceftazidime may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), Ceftazidime may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), Cicletanine may increase the excretion rate of Conjugated estrogens which could result in a lower serum level and potentially a reduction in efficacy.]
[G03CA57, estrogens, conjugated (USP), The excretion of Ceftizoxime can be decreased when combined with Conjugated estrogens.]
[G03CA57, estrogens, conjugated (USP), The excretion of Conjugated estrogens can be decreased when combined with Ceftriaxone.]
[G03CA57, estrogens, conjugated (USP), Cefuroxime may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), The metabolism of Cyclobenzaprine can be decreased when combined with Conjugated estrogens.]
[G03CA57, estrogens, conjugated (USP), Fedratinib may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), The serum concentration of Conjugated estrogens can be decreased when it is combined with Pitolisant.]
[G03CA57, estrogens, conjugated (USP), Istradefylline may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), Cyclothiazide may increase the excretion rate of Conjugated estrogens which could result in a lower serum level and potentially a reduction in efficacy.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may increase the thrombogenic activities of Brolucizumab.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may increase the thrombogenic activities of Brolucizumab.]
[G03CA57, estrogens, conjugated (USP), The therapeutic efficacy of Insulin pork can be decreased when used in combination with Conjugated estrogens.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may increase the thrombogenic activities of Human cytomegalovirus immune globulin.]
[G03CA57, estrogens, conjugated (USP), Daptomycin may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), The excretion of Cephalexin can be decreased when combined with Conjugated estrogens.]
[G03CA57, estrogens, conjugated (USP), The excretion of Cephalexin can be decreased when combined with Conjugated estrogens.]
[G03CA57, estrogens, conjugated (USP), The excretion of Cefaloridine can be decreased when combined with Conjugated estrogens.]
[G03CA57, estrogens, conjugated (USP), The excretion of Conjugated estrogens can be decreased when combined with Cefalotin.]
[G03CA57, estrogens, conjugated (USP), Cefapirin may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), Cefradine may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), The serum concentration of Deflazacort can be increased when it is combined with Conjugated estrogens.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may increase the thrombogenic activities of Trastuzumab.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may increase the thrombogenic activities of Trastuzumab.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may increase the thrombogenic activities of Trastuzumab.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may increase the thrombogenic activities of Trastuzumab.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may increase the thrombogenic activities of Trastuzumab.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may increase the thrombogenic activities of Trastuzumab.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may increase the thrombogenic activities of Trastuzumab emtansine.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may increase the thrombogenic activities of Trastuzumab deruxtecan.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may increase the thrombogenic activities of Trastuzumab deruxtecan.]
[G03CA57, estrogens, conjugated (USP), The serum concentration of Conjugated estrogens can be increased when it is combined with Lasmiditan.]
[G03CA57, estrogens, conjugated (USP), The excretion of Conjugated estrogens can be decreased when combined with Elexacaftor.]
[G03CA57, estrogens, conjugated (USP), The serum concentration of Conjugated estrogens can be decreased when it is combined with Cenobamate.]
[G03CA57, estrogens, conjugated (USP), The serum concentration of Conjugated estrogens can be increased when it is combined with Givosiran.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may decrease the excretion rate of Golodirsen which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may decrease the excretion rate of Dexpanthenol which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), The metabolism of Conjugated estrogens can be decreased when combined with Diacerein.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may increase the thrombogenic activities of Isatuximab.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may increase the thrombogenic activities of Isatuximab.]
[G03CA57, estrogens, conjugated (USP), The excretion of Conjugated estrogens can be decreased when combined with Bempedoic acid.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may increase the thrombogenic activities of Eptinezumab.]
[G03CA57, estrogens, conjugated (USP), The excretion of Conjugated estrogens can be decreased when combined with Remdesivir.]
[G03CA57, estrogens, conjugated (USP), The metabolism of Conjugated estrogens can be decreased when combined with Gatifloxacin.]
[G03CA57, estrogens, conjugated (USP), The metabolism of Conjugated estrogens can be decreased when combined with Gatifloxacin.]
[G03CA57, estrogens, conjugated (USP), The metabolism of Conjugated estrogens can be decreased when combined with Osilodrostat.]
[G03CA57, estrogens, conjugated (USP), The metabolism of Conjugated estrogens can be decreased when combined with Amprenavir.]
[G03CA57, estrogens, conjugated (USP), The metabolism of Frovatriptan can be decreased when combined with Conjugated estrogens.]
[G03CA57, estrogens, conjugated (USP), The metabolism of Selumetinib can be decreased when combined with Conjugated estrogens.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may decrease the excretion rate of Dichlorobenzyl alcohol which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may decrease the excretion rate of Dienogest which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), The metabolism of Conjugated estrogens can be decreased when combined with Rofecoxib.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may decrease the excretion rate of Clevidipine which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), The excretion of Conjugated estrogens can be decreased when combined with Dronedarone.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may decrease the excretion rate of Clorazepic acid which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may decrease the excretion rate of Clorazepic acid which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), The therapeutic efficacy of Thyroid, porcine can be decreased when used in combination with Conjugated estrogens.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may increase the thrombogenic activities of Sacituzumab govitecan.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may increase the thrombogenic activities of Sacituzumab govitecan.]
[G03CA57, estrogens, conjugated (USP), The metabolism of Tucatinib can be decreased when combined with Conjugated estrogens.]
[G03CA57, estrogens, conjugated (USP), The serum concentration of Conjugated estrogens can be increased when it is combined with Capmatinib.]
[G03CA57, estrogens, conjugated (USP), The metabolism of Conjugated estrogens can be decreased when combined with Opicapone.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may decrease the excretion rate of Doxacurium which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), Talniflumate may increase the thrombogenic activities of Conjugated estrogens.]
[G03CA57, estrogens, conjugated (USP), Droxicam may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), The metabolism of 8-chlorotheophylline can be decreased when combined with Conjugated estrogens.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may decrease the anticoagulant activities of Semuloparin.]
[G03CA57, estrogens, conjugated (USP), Ripretinib may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may decrease the excretion rate of Mangafodipir which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may decrease the anticoagulant activities of Lepirudin.]
[G03CA57, estrogens, conjugated (USP), The excretion of Levosalbutamol can be decreased when combined with Conjugated estrogens.]
[G03CA57, estrogens, conjugated (USP), Dexketoprofen may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may increase the thrombogenic activities of Inebilizumab.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may increase the thrombogenic activities of Inebilizumab.]
[G03CA57, estrogens, conjugated (USP), Fostemsavir may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may increase the thrombogenic activities of Tafasitamab.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may increase the thrombogenic activities of Tafasitamab.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may increase the thrombogenic activities of Belantamab mafodotin.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may increase the thrombogenic activities of Belantamab mafodotin.]
[G03CA57, estrogens, conjugated (USP), The serum concentration of Conjugated estrogens can be decreased when it is combined with Satralizumab.]
[G03CA57, estrogens, conjugated (USP), The serum concentration of Conjugated estrogens can be decreased when it is combined with Satralizumab.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may decrease the excretion rate of Chloroquine which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), Pralsetinib may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), Chlorothiazide may increase the excretion rate of Conjugated estrogens which could result in a lower serum level and potentially a reduction in efficacy.]
[G03CA57, estrogens, conjugated (USP), The metabolism of Chlorpromazine can be decreased when combined with Conjugated estrogens.]
[G03CA57, estrogens, conjugated (USP), The therapeutic efficacy of Chlorpropamide can be decreased when used in combination with Conjugated estrogens.]
[G03CA57, estrogens, conjugated (USP), Chlorthalidone may increase the excretion rate of Conjugated estrogens which could result in a lower serum level and potentially a reduction in efficacy.]
[G03CA57, estrogens, conjugated (USP), The metabolism of Chlorzoxazone can be decreased when combined with Conjugated estrogens.]
[G03CA57, estrogens, conjugated (USP), The metabolism of Conjugated estrogens can be decreased when combined with Enrofloxacin.]
[G03CA57, estrogens, conjugated (USP), The excretion of Cholecystokinin can be decreased when combined with Conjugated estrogens.]
[G03CA57, estrogens, conjugated (USP), Cholesterol may increase the excretion rate of Conjugated estrogens which could result in a lower serum level and potentially a reduction in efficacy.]
[G03CA57, estrogens, conjugated (USP), Ethenzamide may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may decrease the excretion rate of Choline C 11 which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may decrease the excretion rate of Choline salicylate which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), Etodolac may increase the thrombogenic activities of Conjugated estrogens.]
[G03CA57, estrogens, conjugated (USP), The therapeutic efficacy of Etofenamate can be decreased when used in combination with Conjugated estrogens.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may increase the thrombogenic activities of Atoltivimab.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may increase the thrombogenic activities of Maftivimab.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may increase the thrombogenic activities of Odesivimab.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may increase the thrombogenic activities of Odesivimab.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may increase the thrombogenic activities of Bamlanivimab.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may increase the thrombogenic activities of Casirivimab.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may increase the thrombogenic activities of Imdevimab.]
[G03CA57, estrogens, conjugated (USP), The metabolism of Conjugated estrogens can be decreased when combined with Berotralstat.]
[G03CA57, estrogens, conjugated (USP), The metabolism of Conjugated estrogens can be decreased when combined with Lonafarnib.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may increase the thrombogenic activities of Ansuvimab.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may increase the thrombogenic activities of Ansuvimab.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may decrease the excretion rate of Chondroitin sulfate which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may increase the thrombogenic activities of Margetuximab.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may increase the thrombogenic activities of Margetuximab.]
[G03CA57, estrogens, conjugated (USP), The excretion of Conjugated estrogens can be decreased when combined with Cabotegravir.]
[G03CA57, estrogens, conjugated (USP), The serum concentration of Conjugated estrogens can be increased when it is combined with Abametapir.]
[G03CA57, estrogens, conjugated (USP), Tepotinib may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), The metabolism of Conjugated estrogens can be increased when combined with Trilaciclib.]
[G03CA57, estrogens, conjugated (USP), Fenbufen may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), The metabolism of Fenethylline can be decreased when combined with Conjugated estrogens.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may decrease the excretion rate of Fenoldopam which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may decrease the excretion rate of Fenproporex which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may decrease the excretion rate of Chromium which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), The excretion of Cefdinir can be decreased when combined with Conjugated estrogens.]
[G03CA57, estrogens, conjugated (USP), The metabolism of Conjugated estrogens can be decreased when combined with Flumequine.]
[G03CA57, estrogens, conjugated (USP), The serum concentration of Flunisolide can be increased when it is combined with Conjugated estrogens.]
[G03CA57, estrogens, conjugated (USP), The serum concentration of Flunisolide can be increased when it is combined with Conjugated estrogens.]
[G03CA57, estrogens, conjugated (USP), Flunixin may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), The excretion of Fluorescein can be decreased when combined with Conjugated estrogens.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may decrease the excretion rate of Flupirtine which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may decrease the excretion rate of Synthetic Conjugated Estrogens, A which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), The therapeutic efficacy of Insulin human can be decreased when used in combination with Conjugated estrogens.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may decrease the anticoagulant activities of Sodium citrate.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may increase the thrombogenic activities of Bevacizumab.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may increase the thrombogenic activities of Bevacizumab.]
[G03CA57, estrogens, conjugated (USP), Tivozanib may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), The serum concentration of Conjugated estrogens can be increased when it is combined with Peginterferon alfa-2b.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may increase the thrombogenic activities of Dostarlimab.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may increase the thrombogenic activities of Dostarlimab.]
[G03CA57, estrogens, conjugated (USP), The excretion of Conjugated estrogens can be decreased when combined with Cilastatin.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may increase the thrombogenic activities of Loncastuximab tesirine.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may increase the thrombogenic activities of Loncastuximab tesirine.]
[G03CA57, estrogens, conjugated (USP), The excretion of Cimetidine can be decreased when combined with Conjugated estrogens.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may decrease the excretion rate of Gabapentin enacarbil which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may decrease the excretion rate of Gadoteridol which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may decrease the excretion rate of Gadopentetic acid which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), The metabolism of Cinnarizine can be decreased when combined with Conjugated estrogens.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may increase the thrombogenic activities of Amivantamab.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may increase the thrombogenic activities of Amivantamab.]
[G03CA57, estrogens, conjugated (USP), The metabolism of Conjugated estrogens can be decreased when combined with Cinoxacin.]
[G03CA57, estrogens, conjugated (USP), The serum concentration of Conjugated estrogens can be decreased when it is combined with Sotorasib.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may increase the thrombogenic activities of Sotrovimab.]
[G03CA57, estrogens, conjugated (USP), The metabolism of Conjugated estrogens can be decreased when combined with Ciprofloxacin.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may decrease the excretion rate of Cisplatin which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), The metabolism of Conjugated estrogens can be decreased when combined with Citalopram.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may increase the thrombogenic activities of Aducanumab.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may increase the thrombogenic activities of Aducanumab.]
[G03CA57, estrogens, conjugated (USP), The therapeutic efficacy of Somapacitan can be decreased when used in combination with Conjugated estrogens.]
[G03CA57, estrogens, conjugated (USP), The therapeutic efficacy of Somapacitan can be decreased when used in combination with Conjugated estrogens.]
[G03CA57, estrogens, conjugated (USP), Finerenone may increase the excretion rate of Conjugated estrogens which could result in a lower serum level and potentially a reduction in efficacy.]
[G03CA57, estrogens, conjugated (USP), Belumosudil may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), The excretion of Conjugated estrogens can be decreased when combined with Fexinidazole.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may increase the thrombogenic activities of Anifrolumab.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may increase the thrombogenic activities of Anifrolumab.]
[G03CA57, estrogens, conjugated (USP), The excretion of Citrulline can be decreased when combined with Conjugated estrogens.]
[G03CA57, estrogens, conjugated (USP), The therapeutic efficacy of Lonapegsomatropin can be decreased when used in combination with Conjugated estrogens.]
[G03CA57, estrogens, conjugated (USP), The therapeutic efficacy of Lonapegsomatropin can be decreased when used in combination with Conjugated estrogens.]
[G03CA57, estrogens, conjugated (USP), Genistein may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may increase the thrombogenic activities of Tisotumab vedotin.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may increase the thrombogenic activities of Tisotumab vedotin.]
[G03CA57, estrogens, conjugated (USP), The serum concentration of Atogepant can be increased when it is combined with Conjugated estrogens.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may decrease the excretion rate of Ioflupane I-123 which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may decrease the excretion rate of Technetium Tc-99m exametazime which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may decrease the excretion rate of Technetium Tc-99m pyrophosphate which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may decrease the excretion rate of Florbetaben (18F) which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), The therapeutic efficacy of Glimepiride can be decreased when used in combination with Conjugated estrogens.]
[G03CA57, estrogens, conjugated (USP), The therapeutic efficacy of Gliquidone can be decreased when used in combination with Conjugated estrogens.]
[G03CA57, estrogens, conjugated (USP), The metabolism of Conjugated estrogens can be increased when combined with St. John's Wort.]
[G03CA57, estrogens, conjugated (USP), The therapeutic efficacy of Exemestane can be decreased when used in combination with Conjugated estrogens.]
[G03CA57, estrogens, conjugated (USP), Maribavir may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), The metabolism of Conjugated estrogens can be decreased when combined with Ropeginterferon alfa-2b.]
[G03CA57, estrogens, conjugated (USP), The metabolism of Conjugated estrogens can be decreased when combined with Ropeginterferon alfa-2b.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may increase the thrombogenic activities of Tixagevimab.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may increase the thrombogenic activities of Cilgavimab.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may increase the thrombogenic activities of Tezepelumab.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may increase the thrombogenic activities of Tralokinumab.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may increase the thrombogenic activities of Sutimlimab.]
[G03CA57, estrogens, conjugated (USP), Clofazimine may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may increase the thrombogenic activities of Bebtelovimab.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may decrease the anticoagulant activities of Tenecteplase.]
[G03CA57, estrogens, conjugated (USP), The metabolism of Levobupivacaine can be decreased when combined with Conjugated estrogens.]
[G03CA57, estrogens, conjugated (USP), The serum concentration of Conjugated estrogens can be increased when it is combined with Pacritinib.]
[G03CA57, estrogens, conjugated (USP), The metabolism of Clomipramine can be decreased when combined with Conjugated estrogens.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may decrease the excretion rate of Clonazepam which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), The metabolism of Clonidine can be decreased when combined with Conjugated estrogens.]
[G03CA57, estrogens, conjugated (USP), The serum concentration of Brincidofovir can be increased when it is combined with Conjugated estrogens.]
[G03CA57, estrogens, conjugated (USP), The serum concentration of Conjugated estrogens can be decreased when it is combined with Mavacamten.]
[G03CA57, estrogens, conjugated (USP), Clonixin may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), The excretion of Oseltamivir can be decreased when combined with Conjugated estrogens.]
[G03CA57, estrogens, conjugated (USP), The serum concentration of Conjugated estrogens can be increased when it is combined with Oteseconazole.]
[G03CA57, estrogens, conjugated (USP), Clopamide may increase the excretion rate of Conjugated estrogens which could result in a lower serum level and potentially a reduction in efficacy.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may increase the thrombogenic activities of Spesolimab.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may increase the thrombogenic activities of Eflapegrastim.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may increase the thrombogenic activities of Tremelimumab.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may increase the thrombogenic activities of Mirvetuximab Soravtansine.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may increase the thrombogenic activities of Mirvetuximab Soravtansine.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may increase the thrombogenic activities of Teplizumab.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may increase the thrombogenic activities of Teplizumab.]
[G03CA57, estrogens, conjugated (USP), The metabolism of Ondansetron can be decreased when combined with Conjugated estrogens.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may increase the thrombogenic activities of Ibritumomab tiuxetan.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may increase the thrombogenic activities of Mosunetuzumab.]
[G03CA57, estrogens, conjugated (USP), The metabolism of Conjugated estrogens can be decreased when combined with Clozapine.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may increase the thrombogenic activities of Lecanemab.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may increase the thrombogenic activities of Ublituximab.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may increase the thrombogenic activities of Tositumomab.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may increase the thrombogenic activities of Panitumumab.]
[G03CA57, estrogens, conjugated (USP), Sotagliflozin may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may decrease the excretion rate of Arbekacin which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may increase the thrombogenic activities of Rozanolixizumab.]
[G03CA57, estrogens, conjugated (USP), The metabolism of Conjugated estrogens can be increased when combined with Somatrogon.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may decrease the excretion rate of Mycophenolic acid which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), The metabolism of Conjugated estrogens can be increased when combined with Bimekizumab.]
[G03CA57, estrogens, conjugated (USP), Proquazone may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), The serum concentration of Sodium ascorbate can be decreased when it is combined with Conjugated estrogens.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may increase the thrombogenic activities of Hepatitis B immune globulin.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may decrease the excretion rate of Colchicine which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), Colistimethate may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may decrease the excretion rate of Colistin which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), Cefpirome may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), The serum concentration of Conjugated estrogens can be decreased when it is combined with Leflunomide.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may decrease the excretion rate of Tropisetron which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may decrease the excretion rate of Nateglinide which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), Imidazole salicylate may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), The therapeutic efficacy of Insulin glargine can be decreased when used in combination with Conjugated estrogens.]
[G03CA57, estrogens, conjugated (USP), The therapeutic efficacy of Insulin glargine can be decreased when used in combination with Conjugated estrogens.]
[G03CA57, estrogens, conjugated (USP), The metabolism of Conjugated estrogens can be decreased when combined with Telithromycin.]
[G03CA57, estrogens, conjugated (USP), Indobufen may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may decrease the excretion rate of Valganciclovir which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may decrease the excretion rate of Invert sugar which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may decrease the excretion rate of Iodixanol which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may decrease the excretion rate of Iopromide which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may decrease the excretion rate of Ioversol which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may decrease the excretion rate of Ioxilan which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), Valdecoxib may increase the thrombogenic activities of Conjugated estrogens.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may decrease the excretion rate of Isosulfan blue which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may decrease the excretion rate of Almotriptan which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), Parecoxib may increase the thrombogenic activities of Conjugated estrogens.]
[G03CA57, estrogens, conjugated (USP), The metabolism of Conjugated estrogens can be decreased when combined with Itraconazole.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may decrease the anticoagulant activities of Bemiparin.]
[G03CA57, estrogens, conjugated (USP), The excretion of Acyclovir can be decreased when combined with Conjugated estrogens.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may decrease the excretion rate of Ketazolam which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), Kebuzone may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), Imatinib may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), The metabolism of Conjugated estrogens can be decreased when combined with Posaconazole.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may decrease the excretion rate of Octinoxate which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens can cause an increase in the absorption of Copper resulting in an increased serum concentration and potentially a worsening of adverse effects.]
[G03CA57, estrogens, conjugated (USP), The excretion of Conjugated estrogens can be decreased when combined with Esomeprazole.]
[G03CA57, estrogens, conjugated (USP), The therapeutic efficacy of Lamotrigine can be decreased when used in combination with Conjugated estrogens.]
[G03CA57, estrogens, conjugated (USP), The serum concentration of Cortisone acetate can be increased when it is combined with Conjugated estrogens.]
[G03CA57, estrogens, conjugated (USP), The serum concentration of Cortisone can be increased when it is combined with Conjugated estrogens.]
[G03CA57, estrogens, conjugated (USP), The metabolism of Lofexidine can be decreased when combined with Conjugated estrogens.]
[G03CA57, estrogens, conjugated (USP), The metabolism of Lomefloxacin can be decreased when combined with Conjugated estrogens.]
[G03CA57, estrogens, conjugated (USP), Lonazolac may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), Loxoprofen may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may decrease the anticoagulant activities of Coumarin.]
[G03CA57, estrogens, conjugated (USP), Loracarbef may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), The risk or severity of angioedema can be increased when Conjugated estrogens is combined with Lisinopril.]
[G03CA57, estrogens, conjugated (USP), The risk or severity of angioedema can be increased when Conjugated estrogens is combined with Lisinopril.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may decrease the excretion rate of Magnesium carbonate which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may decrease the excretion rate of Magnesium trisilicate which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), The serum concentration of Meprednisone can be increased when it is combined with Conjugated estrogens.]
[G03CA57, estrogens, conjugated (USP), The metabolism of Conjugated estrogens can be decreased when combined with Curcumin.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may decrease the excretion rate of Meropenem which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may decrease the excretion rate of Meropenem which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), Eplerenone may increase the excretion rate of Conjugated estrogens which could result in a lower serum level and potentially a reduction in efficacy.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may decrease the excretion rate of Methylnaltrexone which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may decrease the excretion rate of Melperone which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), Cyclopenthiazide may increase the excretion rate of Conjugated estrogens which could result in a lower serum level and potentially a reduction in efficacy.]
[G03CA57, estrogens, conjugated (USP), The excretion of Tenofovir disoproxil can be decreased when combined with Conjugated estrogens.]
[G03CA57, estrogens, conjugated (USP), The metabolism of Conjugated estrogens can be decreased when combined with Cyclosporine.]
[G03CA57, estrogens, conjugated (USP), The metabolism of Conjugated estrogens can be increased when combined with Armodafinil.]
[G03CA57, estrogens, conjugated (USP), The risk or severity of angioedema can be increased when Conjugated estrogens is combined with Moexipril.]
[G03CA57, estrogens, conjugated (USP), The metabolism of Conjugated estrogens can be increased when combined with Cyproterone acetate.]
[G03CA57, estrogens, conjugated (USP), The excretion of Rosuvastatin can be decreased when combined with Conjugated estrogens.]
[G03CA57, estrogens, conjugated (USP), Mofebutazone may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), Morniflumate may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), The metabolism of Conjugated estrogens can be decreased when combined with Conivaptan.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may increase the thrombogenic activities of Omalizumab.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may decrease the excretion rate of Arformoterol which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), The metabolism of Entecavir can be decreased when combined with Conjugated estrogens.]
[G03CA57, estrogens, conjugated (USP), The metabolism of Entecavir can be decreased when combined with Conjugated estrogens.]
[G03CA57, estrogens, conjugated (USP), The metabolism of Etoricoxib can be decreased when combined with Conjugated estrogens.]
[G03CA57, estrogens, conjugated (USP), The metabolism of Dacarbazine can be decreased when combined with Conjugated estrogens.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may decrease the excretion rate of N-acetyltyrosine which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), The metabolism of Conjugated estrogens can be decreased when combined with Danazol.]
[G03CA57, estrogens, conjugated (USP), The therapeutic efficacy of Dantrolene can be decreased when used in combination with Conjugated estrogens.]
[G03CA57, estrogens, conjugated (USP), The risk or severity of adverse effects can be increased when Prasterone is combined with Conjugated estrogens.]
[G03CA57, estrogens, conjugated (USP), The metabolism of Nabumetone can be decreased when combined with Conjugated estrogens.]
[G03CA57, estrogens, conjugated (USP), The therapeutic efficacy of Insulin lispro can be decreased when used in combination with Conjugated estrogens.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may decrease the excretion rate of Nalmefene which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may decrease the excretion rate of Nedocromil which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), The metabolism of Conjugated estrogens can be decreased when combined with Nefazodone.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may decrease the excretion rate of Nicorandil which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may decrease the excretion rate of Nilutamide which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may increase the thrombogenic activities of Cetuximab.]
[G03CA57, estrogens, conjugated (USP), The metabolism of Theodrenaline can be decreased when combined with Conjugated estrogens.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may decrease the anticoagulant activities of Fondaparinux.]
[G03CA57, estrogens, conjugated (USP), Olsalazine may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may decrease the excretion rate of Desipramine which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), Desmopressin may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may decrease the excretion rate of Indigotindisulfonic acid which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may decrease the excretion rate of Indigotindisulfonic acid which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may decrease the excretion rate of Indigotindisulfonic acid which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may decrease the excretion rate of Ertapenem which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), Oxaprozin may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), The excretion of Dexamethasone acetate can be decreased when combined with Conjugated estrogens.]
[G03CA57, estrogens, conjugated (USP), The excretion of Dexamethasone acetate can be decreased when combined with Conjugated estrogens.]
[G03CA57, estrogens, conjugated (USP), The serum concentration of Dexamethasone can be increased when it is combined with Conjugated estrogens.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may decrease the excretion rate of Oxybenzone which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), The metabolism of Dexfenfluramine can be decreased when combined with Conjugated estrogens.]
[G03CA57, estrogens, conjugated (USP), The metabolism of Conjugated estrogens can be increased when combined with Adalimumab.]
[G03CA57, estrogens, conjugated (USP), The metabolism of Conjugated estrogens can be increased when combined with Adalimumab.]
[G03CA57, estrogens, conjugated (USP), The metabolism of Conjugated estrogens can be increased when combined with Adalimumab.]
[G03CA57, estrogens, conjugated (USP), The metabolism of Conjugated estrogens can be increased when combined with Adalimumab.]
[G03CA57, estrogens, conjugated (USP), The metabolism of Conjugated estrogens can be increased when combined with Adalimumab.]
[G03CA57, estrogens, conjugated (USP), The metabolism of Conjugated estrogens can be increased when combined with Adalimumab.]
[G03CA57, estrogens, conjugated (USP), The metabolism of Conjugated estrogens can be increased when combined with Adalimumab.]
[G03CA57, estrogens, conjugated (USP), Gefitinib may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), Amphetamine may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), The metabolism of Paroxetine can be decreased when combined with Conjugated estrogens.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may decrease the excretion rate of Patent Blue which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), The metabolism of Clopidogrel can be decreased when combined with Conjugated estrogens.]
[G03CA57, estrogens, conjugated (USP), The metabolism of Pentifylline can be decreased when combined with Conjugated estrogens.]
[G03CA57, estrogens, conjugated (USP), Diatrizoate may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may decrease the excretion rate of Permethrin which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may decrease the excretion rate of Diazepam which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), The serum concentration of Dibenzepin can be increased when it is combined with Conjugated estrogens.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may decrease the excretion rate of Pholcodine which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), Diclofenamide may increase the excretion rate of Conjugated estrogens which could result in a lower serum level and potentially a reduction in efficacy.]
[G03CA57, estrogens, conjugated (USP), The excretion of Conjugated estrogens can be decreased when combined with Diclofenac.]
[G03CA57, estrogens, conjugated (USP), Foscarnet may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may decrease the excretion rate of Dicyclomine which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may decrease the excretion rate of Didanosine which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), The metabolism of Erlotinib can be decreased when combined with Conjugated estrogens.]
[G03CA57, estrogens, conjugated (USP), Piretanide may increase the excretion rate of Conjugated estrogens which could result in a lower serum level and potentially a reduction in efficacy.]
[G03CA57, estrogens, conjugated (USP), Diethylstilbestrol may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), The metabolism of Conjugated estrogens can be decreased when combined with Isradipine.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may decrease the excretion rate of Difluocortolone which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), Diflunisal may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may decrease the excretion rate of Digoxin which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), The metabolism of Conjugated estrogens can be decreased when combined with Dihydralazine.]
[G03CA57, estrogens, conjugated (USP), The excretion of Ezetimibe can be decreased when combined with Conjugated estrogens.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may decrease the excretion rate of Hydromorphone which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may increase the thrombogenic activities of Lenalidomide.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may decrease the excretion rate of Potassium bicarbonate which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), The metabolism of Conjugated estrogens can be decreased when combined with Atazanavir.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may decrease the excretion rate of Potassium nitrate which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may decrease the excretion rate of Potassium perchlorate which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may decrease the excretion rate of Potassium sulfate which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may decrease the excretion rate of Pralidoxime which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), The metabolism of Conjugated estrogens can be decreased when combined with Diltiazem.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may decrease the excretion rate of Dimercaprol which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may decrease the excretion rate of Dimethyl sulfoxide which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), The metabolism of Propentofylline can be decreased when combined with Conjugated estrogens.]
[G03CA57, estrogens, conjugated (USP), Propyphenazone may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), Proglumetacin may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), The excretion of Dinoprostone can be decreased when combined with Conjugated estrogens.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may decrease the anticoagulant activities of Protein S human.]
[G03CA57, estrogens, conjugated (USP), The metabolism of Proxyphylline can be decreased when combined with Conjugated estrogens.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may decrease the excretion rate of Pyrithione which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), The excretion of Quinapril can be decreased when combined with Conjugated estrogens.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may decrease the anticoagulant activities of Dipyridamole.]
[G03CA57, estrogens, conjugated (USP), Metamizole may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may decrease the anticoagulant activities of Drotrecogin alfa.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may decrease the anticoagulant activities of Drotrecogin alfa.]
[G03CA57, estrogens, conjugated (USP), The therapeutic efficacy of Insulin aspart can be decreased when used in combination with Conjugated estrogens.]
[G03CA57, estrogens, conjugated (USP), The serum concentration of Quinupramine can be increased when it is combined with Conjugated estrogens.]
[G03CA57, estrogens, conjugated (USP), The risk or severity of angioedema can be increased when Ramipril is combined with Conjugated estrogens.]
[G03CA57, estrogens, conjugated (USP), The risk or severity of angioedema can be increased when Conjugated estrogens is combined with Sirolimus.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may decrease the excretion rate of Resorcinol which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), The metabolism of Conjugated estrogens can be decreased when combined with Disopyramide.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may increase the thrombogenic activities of Human Rho(D) immune globulin.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may increase the thrombogenic activities of Human Rho(D) immune globulin.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may increase the thrombogenic activities of Natalizumab.]
[G03CA57, estrogens, conjugated (USP), The metabolism of Conjugated estrogens can be increased when combined with Rifamycin.]
[G03CA57, estrogens, conjugated (USP), The metabolism of Conjugated estrogens can be increased when combined with Rifapentine.]
[G03CA57, estrogens, conjugated (USP), The metabolism of Riluzole can be decreased when combined with Conjugated estrogens.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may decrease the excretion rate of Levocetirizine which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may increase the thrombogenic activities of Efalizumab.]
[G03CA57, estrogens, conjugated (USP), The metabolism of Ropivacaine can be decreased when combined with Conjugated estrogens.]
[G03CA57, estrogens, conjugated (USP), The metabolism of Conjugated estrogens can be decreased when combined with Rosoxacin.]
[G03CA57, estrogens, conjugated (USP), Sunitinib may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), The metabolism of Conjugated estrogens can be decreased when combined with Aprepitant.]
[G03CA57, estrogens, conjugated (USP), Tolvaptan may increase the excretion rate of Conjugated estrogens which could result in a lower serum level and potentially a reduction in efficacy.]
[G03CA57, estrogens, conjugated (USP), The metabolism of Conjugated estrogens can be decreased when combined with Bortezomib.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may decrease the excretion rate of Tadalafil which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), Ketorolac may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), The excretion of Ambrisentan can be decreased when combined with Conjugated estrogens.]
[G03CA57, estrogens, conjugated (USP), Ranolazine may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), Salsalate may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), Salmon calcitonin may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may decrease the excretion rate of Dobutamine which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), The metabolism of Domperidone can be decreased when combined with Conjugated estrogens.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may decrease the excretion rate of Dopamine which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), The metabolism of Conjugated estrogens can be decreased when combined with Dosulepin.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may decrease the excretion rate of Selenious acid which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), The metabolism of Doxepin can be decreased when combined with Conjugated estrogens.]
[G03CA57, estrogens, conjugated (USP), Doxycycline may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), Doxycycline may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may decrease the excretion rate of Sibutramine which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), The excretion of Simvastatin can be decreased when combined with Conjugated estrogens.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may decrease the excretion rate of Sodium sulfate which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may decrease the excretion rate of Sodium sulfate which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), The risk or severity of angioedema can be increased when Conjugated estrogens is combined with Spirapril.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may decrease the excretion rate of Dyphylline which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may decrease the excretion rate of Strontium chloride which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), The excretion of Succinic acid can be decreased when combined with Conjugated estrogens.]
[G03CA57, estrogens, conjugated (USP), The excretion of Sumatriptan can be decreased when combined with Conjugated estrogens.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may decrease the excretion rate of Edrophonium which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may decrease the excretion rate of Edrophonium which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may decrease the anticoagulant activities of Edetic acid.]
[G03CA57, estrogens, conjugated (USP), The serum concentration of Corticotropin can be increased when it is combined with Conjugated estrogens.]
[G03CA57, estrogens, conjugated (USP), The excretion of Tazobactam can be decreased when combined with Conjugated estrogens.]
[G03CA57, estrogens, conjugated (USP), The metabolism of Conjugated estrogens can be decreased when combined with Temafloxacin.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may decrease the excretion rate of Temozolomide which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), The excretion of Conjugated estrogens can be decreased when combined with Tenoxicam.]
[G03CA57, estrogens, conjugated (USP), The metabolism of Terbinafine can be decreased when combined with Conjugated estrogens.]
[G03CA57, estrogens, conjugated (USP), The serum concentration of Tianeptine can be increased when it is combined with Conjugated estrogens.]
[G03CA57, estrogens, conjugated (USP), The excretion of Conjugated estrogens can be decreased when combined with Enalapril.]
[G03CA57, estrogens, conjugated (USP), The risk or severity of angioedema can be increased when Conjugated estrogens is combined with Enalaprilat.]
[G03CA57, estrogens, conjugated (USP), The risk or severity of angioedema can be increased when Conjugated estrogens is combined with Enalaprilat.]
[G03CA57, estrogens, conjugated (USP), Tolfenamic acid may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may decrease the excretion rate of Toloxatone which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may decrease the excretion rate of Atomoxetine which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), Topiramate may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), Torasemide may increase the excretion rate of Conjugated estrogens which could result in a lower serum level and potentially a reduction in efficacy.]
[G03CA57, estrogens, conjugated (USP), The risk or severity of angioedema can be increased when Conjugated estrogens is combined with Trandolapril.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may decrease the excretion rate of Chloral hydrate which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may decrease the anticoagulant activities of Triflusal.]
[G03CA57, estrogens, conjugated (USP), The serum concentration of Trilostane can be increased when it is combined with Conjugated estrogens.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may decrease the anticoagulant activities of Troxerutin.]
[G03CA57, estrogens, conjugated (USP), The metabolism of Conjugated estrogens can be decreased when combined with Enoxacin.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may increase the thrombogenic activities of Human varicella-zoster immune globulin.]
[G03CA57, estrogens, conjugated (USP), Venlafaxine may increase the excretion rate of Conjugated estrogens which could result in a lower serum level and potentially a reduction in efficacy.]
[G03CA57, estrogens, conjugated (USP), The metabolism of Conjugated estrogens can be decreased when combined with Barnidipine.]
[G03CA57, estrogens, conjugated (USP), The risk or severity of angioedema can be increased when Conjugated estrogens is combined with Zofenopril.]
[G03CA57, estrogens, conjugated (USP), The metabolism of Zolpidem can be decreased when combined with Conjugated estrogens.]
[G03CA57, estrogens, conjugated (USP), Zomepirac may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), Zonisamide may increase the excretion rate of Conjugated estrogens which could result in a lower serum level and potentially a reduction in efficacy.]
[G03CA57, estrogens, conjugated (USP), The therapeutic efficacy of Insulin glulisine can be decreased when used in combination with Conjugated estrogens.]
[G03CA57, estrogens, conjugated (USP), The metabolism of Zotepine can be decreased when combined with Conjugated estrogens.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may decrease the anticoagulant activities of Anistreplase.]
[G03CA57, estrogens, conjugated (USP), Carboplatin may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may decrease the excretion rate of Guanfacine which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), The metabolism of Conjugated estrogens can be decreased when combined with Ergotamine.]
[G03CA57, estrogens, conjugated (USP), The excretion of Valproic acid can be decreased when combined with Conjugated estrogens.]
[G03CA57, estrogens, conjugated (USP), The excretion of Valproic acid can be decreased when combined with Conjugated estrogens.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may decrease the excretion rate of Pidotimod which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), The metabolism of Conjugated estrogens can be decreased when combined with Erythromycin.]
[G03CA57, estrogens, conjugated (USP), The metabolism of Conjugated estrogens can be decreased when combined with Zileuton.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may decrease the excretion rate of Estazolam which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), The excretion of Conjugated estrogens can be decreased when combined with Pantoprazole.]
[G03CA57, estrogens, conjugated (USP), The metabolism of Cinacalcet can be decreased when combined with Conjugated estrogens.]
[G03CA57, estrogens, conjugated (USP), The excretion of Estradiol can be decreased when combined with Conjugated estrogens.]
[G03CA57, estrogens, conjugated (USP), Estradiol acetate may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), Estradiol cypionate may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), Estradiol valerate may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may increase the thrombogenic activities of Antilymphocyte immunoglobulin (horse).]
[G03CA57, estrogens, conjugated (USP), The excretion of Conjugated estrogens can be increased when combined with Testosterone cypionate.]
[G03CA57, estrogens, conjugated (USP), The metabolism of Theophylline can be decreased when combined with Conjugated estrogens.]
[G03CA57, estrogens, conjugated (USP), The metabolism of Conjugated estrogens can be decreased when combined with Fusidic acid.]
[G03CA57, estrogens, conjugated (USP), The metabolism of Conjugated estrogens can be decreased when combined with Pipemidic acid.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may increase the thrombogenic activities of Tetanus immune globulin, human.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may decrease the excretion rate of Clevidipine which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may decrease the excretion rate of Fluocinolone acetonide which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), The metabolism of Mefenamic acid can be decreased when combined with Conjugated estrogens.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may decrease the excretion rate of Pentaerythritol tetranitrate which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may increase the thrombogenic activities of Human varicella-zoster immune globulin.]
[G03CA57, estrogens, conjugated (USP), Estradiol benzoate may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may decrease the excretion rate of Ethambutol which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), The excretion of Conjugated estrogens can be decreased when combined with Fluticasone propionate.]
[G03CA57, estrogens, conjugated (USP), The excretion of Conjugated estrogens can be decreased when combined with Fluticasone furoate.]
[G03CA57, estrogens, conjugated (USP), The excretion of Conjugated estrogens can be decreased when combined with Fluticasone.]
[G03CA57, estrogens, conjugated (USP), The excretion of Fluvastatin can be decreased when combined with Conjugated estrogens.]
[G03CA57, estrogens, conjugated (USP), Gadodiamide may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), The metabolism of Ethinylestradiol can be decreased when combined with Conjugated estrogens.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may decrease the excretion rate of Ibutilide which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), The therapeutic efficacy of Ethotoin can be decreased when used in combination with Conjugated estrogens.]
[G03CA57, estrogens, conjugated (USP), Meloxicam may increase the thrombogenic activities of Conjugated estrogens.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may decrease the excretion rate of Etomidate which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), The metabolism of Etoposide can be decreased when combined with Conjugated estrogens.]
[G03CA57, estrogens, conjugated (USP), The excretion of Conjugated estrogens can be decreased when combined with Tacrolimus.]
[G03CA57, estrogens, conjugated (USP), The metabolism of Conjugated estrogens can be decreased when combined with Terfenadine.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may decrease the excretion rate of Trimetrexate which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may decrease the excretion rate of Bupropion which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may decrease the excretion rate of Lithium carbonate which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), The metabolism of Conjugated estrogens can be decreased when combined with Fluvoxamine.]
[G03CA57, estrogens, conjugated (USP), The metabolism of Tocainide can be decreased when combined with Conjugated estrogens.]
[G03CA57, estrogens, conjugated (USP), Leuprolide may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may increase the thrombogenic activities of Muromonab.]
[G03CA57, estrogens, conjugated (USP), The excretion of Conjugated estrogens can be decreased when combined with Pravastatin.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may decrease the excretion rate of Sodium aurothiomalate which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may decrease the anticoagulant activities of Dextran.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may decrease the excretion rate of Dexrazoxane which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), The excretion of Famotidine can be decreased when combined with Conjugated estrogens.]
[G03CA57, estrogens, conjugated (USP), The excretion of Aminohippuric acid can be decreased when combined with Conjugated estrogens.]
[G03CA57, estrogens, conjugated (USP), Pyridoxine may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), The excretion of Levocarnitine can be decreased when combined with Conjugated estrogens.]
[G03CA57, estrogens, conjugated (USP), The metabolism of Conjugated estrogens can be increased when combined with Albendazole.]
[G03CA57, estrogens, conjugated (USP), The metabolism of Fenfluramine can be decreased when combined with Conjugated estrogens.]
[G03CA57, estrogens, conjugated (USP), Fenoprofen may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may decrease the excretion rate of Fentanyl which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may decrease the excretion rate of Salbutamol which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may decrease the anticoagulant activities of Fibrinolysin.]
[G03CA57, estrogens, conjugated (USP), The excretion of Clofarabine can be decreased when combined with Conjugated estrogens.]
[G03CA57, estrogens, conjugated (USP), Cevimeline may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may decrease the excretion rate of Flavoxate which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), The metabolism of Flecainide can be decreased when combined with Conjugated estrogens.]
[G03CA57, estrogens, conjugated (USP), Floctafenine may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), The metabolism of Conjugated estrogens can be decreased when combined with Fluconazole.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may decrease the excretion rate of Flucytosine which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), The serum concentration of Fludrocortisone can be increased when it is combined with Conjugated estrogens.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may decrease the excretion rate of Flumazenil which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), The metabolism of Flunarizine can be decreased when combined with Conjugated estrogens.]
[G03CA57, estrogens, conjugated (USP), The serum concentration of Melitracen can be increased when it is combined with Conjugated estrogens.]
[G03CA57, estrogens, conjugated (USP), The metabolism of Ethanol can be decreased when combined with Conjugated estrogens.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may decrease the excretion rate of Floxuridine which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), The metabolism of Fluorouracil can be decreased when combined with Conjugated estrogens.]
[G03CA57, estrogens, conjugated (USP), The metabolism of Conjugated estrogens can be decreased when combined with Fluoxetine.]
[G03CA57, estrogens, conjugated (USP), The serum concentration of Fluprednisolone can be increased when it is combined with Conjugated estrogens.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may decrease the excretion rate of Flurazepam which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), Flurbiprofen may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), The metabolism of Flutamide can be decreased when combined with Conjugated estrogens.]
[G03CA57, estrogens, conjugated (USP), Folic acid may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may decrease the excretion rate of Fosfomycin which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), Framycetin may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), The metabolism of Tegafur can be decreased when combined with Conjugated estrogens.]
[G03CA57, estrogens, conjugated (USP), The metabolism of Conjugated estrogens can be decreased when combined with Darunavir.]
[G03CA57, estrogens, conjugated (USP), The therapeutic efficacy of Furosemide can be decreased when used in combination with Conjugated estrogens.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may decrease the excretion rate of Eszopiclone which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), The excretion of Conjugated estrogens can be decreased when combined with Ganciclovir.]
[G03CA57, estrogens, conjugated (USP), The excretion of Conjugated estrogens can be decreased when combined with Gemfibrozil.]
[G03CA57, estrogens, conjugated (USP), Firocoxib may increase the thrombogenic activities of Conjugated estrogens.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may decrease the excretion rate of Telavancin which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), The metabolism of Dasatinib can be decreased when combined with Conjugated estrogens.]
[G03CA57, estrogens, conjugated (USP), The metabolism of Cafedrine can be decreased when combined with Conjugated estrogens.]
[G03CA57, estrogens, conjugated (USP), Butabarbital may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), The therapeutic efficacy of Glyburide can be decreased when used in combination with Conjugated estrogens.]
[G03CA57, estrogens, conjugated (USP), The therapeutic efficacy of Gliclazide can be decreased when used in combination with Conjugated estrogens.]
[G03CA57, estrogens, conjugated (USP), The therapeutic efficacy of Glipizide can be decreased when used in combination with Conjugated estrogens.]
[G03CA57, estrogens, conjugated (USP), The metabolism of Conjugated estrogens can be decreased when combined with Dexmedetomidine.]
[G03CA57, estrogens, conjugated (USP), The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Conjugated estrogens.]
[G03CA57, estrogens, conjugated (USP), The metabolism of Sorafenib can be decreased when combined with Conjugated estrogens.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may decrease the excretion rate of Aurothioglucose which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may decrease the excretion rate of Pegaptanib which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may decrease the excretion rate of Pegaptanib which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may decrease the anticoagulant activities of Fluindione.]
[G03CA57, estrogens, conjugated (USP), The risk or severity of angioedema can be increased when Conjugated estrogens is combined with Fosinopril.]
[G03CA57, estrogens, conjugated (USP), The metabolism of Guanabenz can be decreased when combined with Conjugated estrogens.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may decrease the excretion rate of Guanethidine which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), Goserelin may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), The excretion of Conjugated estrogens can be decreased when combined with Guanidine.]
[G03CA57, estrogens, conjugated (USP), The therapeutic efficacy of Allantoin can be decreased when used in combination with Conjugated estrogens.]
[G03CA57, estrogens, conjugated (USP), The serum concentration of Haloperidol can be increased when it is combined with Conjugated estrogens.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may decrease the excretion rate of Quetiapine which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may decrease the excretion rate of Idebenone which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), The therapeutic efficacy of Insulin aspart can be decreased when used in combination with Conjugated estrogens.]
[G03CA57, estrogens, conjugated (USP), The excretion of Conjugated estrogens can be decreased when combined with Irinotecan.]
[G03CA57, estrogens, conjugated (USP), The excretion of Allopurinol can be decreased when combined with Conjugated estrogens.]
[G03CA57, estrogens, conjugated (USP), Lithium citrate may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), The risk or severity of angioedema can be increased when Conjugated estrogens is combined with Losartan.]
[G03CA57, estrogens, conjugated (USP), The therapeutic efficacy of Heparin can be decreased when used in combination with Conjugated estrogens.]
[G03CA57, estrogens, conjugated (USP), Magnesium salicylate may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may decrease the excretion rate of Allylestrenol which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), The excretion of Mesalazine can be decreased when combined with Conjugated estrogens.]
[G03CA57, estrogens, conjugated (USP), Milrinone may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), The metabolism of Conjugated estrogens can be decreased when combined with Nevirapine.]
[G03CA57, estrogens, conjugated (USP), The metabolism of Conjugated estrogens can be decreased when combined with Nilvadipine.]
[G03CA57, estrogens, conjugated (USP), Nimesulide may increase the thrombogenic activities of Conjugated estrogens.]
[G03CA57, estrogens, conjugated (USP), The risk or severity of angioedema can be increased when Conjugated estrogens is combined with Perindopril.]
[G03CA57, estrogens, conjugated (USP), The therapeutic efficacy of Hyaluronidase (ovine) can be decreased when used in combination with Conjugated estrogens.]
[G03CA57, estrogens, conjugated (USP), The therapeutic efficacy of Hyaluronidase can be decreased when used in combination with Conjugated estrogens.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may decrease the excretion rate of Hydralazine which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), The excretion of Hydrochlorothiazide can be decreased when combined with Conjugated estrogens.]
[G03CA57, estrogens, conjugated (USP), The serum concentration of Hydrocortisone can be increased when it is combined with Conjugated estrogens.]
[G03CA57, estrogens, conjugated (USP), Hydroflumethiazide may increase the excretion rate of Conjugated estrogens which could result in a lower serum level and potentially a reduction in efficacy.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may decrease the excretion rate of Potassium acetate which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), Potassium citrate may increase the excretion rate of Conjugated estrogens which could result in a lower serum level and potentially a reduction in efficacy.]
[G03CA57, estrogens, conjugated (USP), Hydroxocobalamin may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may decrease the excretion rate of Propiverine which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may decrease the excretion rate of Hydroxyethyl Starch which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), The excretion of Conjugated estrogens can be decreased when combined with Ibuprofen.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may decrease the excretion rate of Sodium acetate which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may decrease the anticoagulant activities of Sodium citrate.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may decrease the excretion rate of Ifosfamide which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), The metabolism of Conjugated estrogens can be increased when combined with Somatrem.]
[G03CA57, estrogens, conjugated (USP), The metabolism of Imipramine can be decreased when combined with Conjugated estrogens.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may decrease the excretion rate of Tiludronic acid which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may decrease the excretion rate of Tixocortol which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), The serum concentration of Tizanidine can be increased when it is combined with Conjugated estrogens.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may decrease the excretion rate of Topotecan which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), Indapamide may increase the excretion rate of Conjugated estrogens which could result in a lower serum level and potentially a reduction in efficacy.]
[G03CA57, estrogens, conjugated (USP), The excretion of Indomethacin can be decreased when combined with Conjugated estrogens.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may decrease the excretion rate of Inositol which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), The metabolism of Conjugated estrogens can be decreased when combined with Interferon alfa-2a.]
[G03CA57, estrogens, conjugated (USP), The metabolism of Conjugated estrogens can be decreased when combined with Interferon alfa-2b.]
[G03CA57, estrogens, conjugated (USP), The therapeutic efficacy of Meclofenamic acid can be decreased when used in combination with Conjugated estrogens.]
[G03CA57, estrogens, conjugated (USP), The metabolism of Conjugated estrogens can be decreased when combined with Interferon gamma-1b.]
[G03CA57, estrogens, conjugated (USP), The metabolism of Conjugated estrogens can be decreased when combined with Milnacipran.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may decrease the excretion rate of Metaxalone which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may decrease the excretion rate of Eucalyptus oil which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may decrease the excretion rate of Varenicline which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may increase the thrombogenic activities of Eculizumab.]
[G03CA57, estrogens, conjugated (USP), The excretion of Sitagliptin can be decreased when combined with Conjugated estrogens.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may increase the thrombogenic activities of Ranibizumab.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may decrease the excretion rate of Alprazolam which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), The metabolism of Ramelteon can be decreased when combined with Conjugated estrogens.]
[G03CA57, estrogens, conjugated (USP), The risk or severity of angioedema can be increased when Conjugated estrogens is combined with Vildagliptin.]
[G03CA57, estrogens, conjugated (USP), The excretion of Cerivastatin can be decreased when combined with Conjugated estrogens.]
[G03CA57, estrogens, conjugated (USP), The metabolism of Anagrelide can be decreased when combined with Conjugated estrogens.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may decrease the excretion rate of Iothalamic acid which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), Quinethazone may increase the excretion rate of Conjugated estrogens which could result in a lower serum level and potentially a reduction in efficacy.]
[G03CA57, estrogens, conjugated (USP), The metabolism of Conjugated estrogens can be decreased when combined with Interferon alfacon-1.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may decrease the excretion rate of Ipecac which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), The serum concentration of Iprindole can be increased when it is combined with Conjugated estrogens.]
[G03CA57, estrogens, conjugated (USP), The excretion of Alprostadil can be decreased when combined with Conjugated estrogens.]
[G03CA57, estrogens, conjugated (USP), The metabolism of Penciclovir can be decreased when combined with Conjugated estrogens.]
[G03CA57, estrogens, conjugated (USP), The risk or severity of angioedema can be increased when Conjugated estrogens is combined with Imidapril.]
[G03CA57, estrogens, conjugated (USP), The metabolism of Conjugated estrogens can be decreased when combined with Entacapone.]
[G03CA57, estrogens, conjugated (USP), The metabolism of Conjugated estrogens can be decreased when combined with Isoniazid.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may decrease the excretion rate of Inosine pranobex which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), Isosorbide may increase the excretion rate of Conjugated estrogens which could result in a lower serum level and potentially a reduction in efficacy.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may decrease the excretion rate of Isotretinoin which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), The excretion of Conjugated estrogens can be decreased when combined with Ivermectin.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may decrease the anticoagulant activities of Bivalirudin.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may decrease the excretion rate of Kanamycin which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), The therapeutic efficacy of Somatotropin can be decreased when used in combination with Conjugated estrogens.]
[G03CA57, estrogens, conjugated (USP), The metabolism of Conjugated estrogens can be increased when combined with Tocilizumab.]
[G03CA57, estrogens, conjugated (USP), The metabolism of Conjugated estrogens can be decreased when combined with Interferon alfa-n3.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may decrease the excretion rate of Ketamine which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may decrease the anticoagulant activities of Prasugrel.]
[G03CA57, estrogens, conjugated (USP), The metabolism of Conjugated estrogens can be decreased when combined with Ketoconazole.]
[G03CA57, estrogens, conjugated (USP), The metabolism of Olanzapine can be decreased when combined with Conjugated estrogens.]
[G03CA57, estrogens, conjugated (USP), The excretion of Conjugated estrogens can be decreased when combined with Ketoprofen.]
[G03CA57, estrogens, conjugated (USP), The serum concentration of Conjugated estrogens can be increased when it is combined with Deferasirox.]
[G03CA57, estrogens, conjugated (USP), The metabolism of Conjugated estrogens can be increased when combined with Abatacept.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may decrease the excretion rate of Synthetic Conjugated Estrogens, B which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may decrease the excretion rate of Pentetic acid which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), The metabolism of Conjugated estrogens can be decreased when combined with Nalidixic acid.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may decrease the excretion rate of Labetalol which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), Icosapent may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), Canrenoic acid may increase the excretion rate of Conjugated estrogens which could result in a lower serum level and potentially a reduction in efficacy.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may decrease the excretion rate of Amantadine which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may decrease the excretion rate of Lubiprostone which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), Etacrynic acid may increase the excretion rate of Conjugated estrogens which could result in a lower serum level and potentially a reduction in efficacy.]
[G03CA57, estrogens, conjugated (USP), Etacrynic acid may increase the excretion rate of Conjugated estrogens which could result in a lower serum level and potentially a reduction in efficacy.]
[G03CA57, estrogens, conjugated (USP), Folic acid may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), The excretion of Leucovorin can be decreased when combined with Conjugated estrogens.]
[G03CA57, estrogens, conjugated (USP), The therapeutic efficacy of Insulin human can be decreased when used in combination with Conjugated estrogens.]
[G03CA57, estrogens, conjugated (USP), The metabolism of Conjugated estrogens can be decreased when combined with Lidocaine.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may decrease the excretion rate of Amikacin which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), The metabolism of Conjugated estrogens can be increased when combined with Armodafinil.]
[G03CA57, estrogens, conjugated (USP), Amiloride may increase the excretion rate of Conjugated estrogens which could result in a lower serum level and potentially a reduction in efficacy.]
[G03CA57, estrogens, conjugated (USP), The serum concentration of Lofepramine can be increased when it is combined with Conjugated estrogens.]
[G03CA57, estrogens, conjugated (USP), Lorazepam may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), The metabolism of Conjugated estrogens can be decreased when combined with Lovastatin.]
[G03CA57, estrogens, conjugated (USP), The serum concentration of Magnesium can be decreased when it is combined with Conjugated estrogens.]
[G03CA57, estrogens, conjugated (USP), The risk or severity of angioedema can be increased when Conjugated estrogens is combined with Temsirolimus.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may decrease the excretion rate of Magnesium chloride which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may decrease the excretion rate of Magnesium hydroxide which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may decrease the excretion rate of Pralatrexate which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), The metabolism of Conjugated estrogens can be decreased when combined with Nilotinib.]
[G03CA57, estrogens, conjugated (USP), Mannitol may increase the excretion rate of Conjugated estrogens which could result in a lower serum level and potentially a reduction in efficacy.]
[G03CA57, estrogens, conjugated (USP), The metabolism of Maprotiline can be decreased when combined with Conjugated estrogens.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may decrease the excretion rate of Mecamylamine which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), The therapeutic efficacy of Meclofenamic acid can be decreased when used in combination with Conjugated estrogens.]
[G03CA57, estrogens, conjugated (USP), Mefruside may increase the excretion rate of Conjugated estrogens which could result in a lower serum level and potentially a reduction in efficacy.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may decrease the anticoagulant activities of Nadroparin.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may decrease the anticoagulant activities of Enoxaparin.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may decrease the anticoagulant activities of Dalteparin.]
[G03CA57, estrogens, conjugated (USP), The excretion of Conjugated estrogens can be decreased when combined with Melatonin.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may decrease the excretion rate of Memantine which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may decrease the excretion rate of Meperidine which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), The therapeutic efficacy of Mephenytoin can be decreased when used in combination with Conjugated estrogens.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may decrease the excretion rate of Mepivacaine which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may decrease the excretion rate of Tiopronin which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), Mersalyl may increase the excretion rate of Conjugated estrogens which could result in a lower serum level and potentially a reduction in efficacy.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may decrease the excretion rate of Paliperidone which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may decrease the excretion rate of Metformin which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), The excretion of Mycophenolate mofetil can be decreased when combined with Conjugated estrogens.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may decrease the excretion rate of Metamfetamine which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may decrease the excretion rate of Lamivudine which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), Methazolamide may increase the excretion rate of Conjugated estrogens which could result in a lower serum level and potentially a reduction in efficacy.]
[G03CA57, estrogens, conjugated (USP), The metabolism of Conjugated estrogens can be decreased when combined with Methimazole.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may decrease the excretion rate of Pemetrexed which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), Pyridoxine may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), The excretion of Methotrexate can be decreased when combined with Conjugated estrogens.]
[G03CA57, estrogens, conjugated (USP), The metabolism of Conjugated estrogens can be decreased when combined with Methoxsalen.]
[G03CA57, estrogens, conjugated (USP), Methyclothiazide may increase the excretion rate of Conjugated estrogens which could result in a lower serum level and potentially a reduction in efficacy.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may decrease the excretion rate of Methyldopa which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), The metabolism of Conjugated estrogens can be increased when combined with Methylene blue.]
[G03CA57, estrogens, conjugated (USP), The metabolism of Aminophylline can be decreased when combined with Conjugated estrogens.]
[G03CA57, estrogens, conjugated (USP), The serum concentration of Methylprednisolone can be increased when it is combined with Conjugated estrogens.]
[G03CA57, estrogens, conjugated (USP), The excretion of Conjugated estrogens can be increased when combined with Methyltestosterone.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may decrease the excretion rate of Tiotropium which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), The metabolism of Metoclopramide can be decreased when combined with Conjugated estrogens.]
[G03CA57, estrogens, conjugated (USP), Metolazone may increase the excretion rate of Conjugated estrogens which could result in a lower serum level and potentially a reduction in efficacy.]
[G03CA57, estrogens, conjugated (USP), Metoprolol may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may decrease the excretion rate of Metyrapone which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), The metabolism of Conjugated estrogens can be decreased when combined with Mexiletine.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may decrease the excretion rate of Gadobenic acid which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), The metabolism of Mianserin can be decreased when combined with Conjugated estrogens.]
[G03CA57, estrogens, conjugated (USP), The metabolism of Conjugated estrogens can be decreased when combined with Miconazole.]
[G03CA57, estrogens, conjugated (USP), The metabolism of Aminophenazone can be decreased when combined with Conjugated estrogens.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may decrease the anticoagulant activities of Parnaparin.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may decrease the excretion rate of Midazolam which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), The excretion of Conjugated estrogens can be decreased when combined with Mifepristone.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may decrease the anticoagulant activities of Tinzaparin.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may decrease the excretion rate of Zanamivir which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), The risk or severity of angioedema can be increased when Valsartan is combined with Conjugated estrogens.]
[G03CA57, estrogens, conjugated (USP), The excretion of Conjugated estrogens can be decreased when combined with Minocycline.]
[G03CA57, estrogens, conjugated (USP), The metabolism of Conjugated estrogens can be increased when combined with Mitotane.]
[G03CA57, estrogens, conjugated (USP), Aldesleukin may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), The metabolism of Conjugated estrogens can be decreased when combined with Amiodarone.]
[G03CA57, estrogens, conjugated (USP), The metabolism of Amitriptyline can be decreased when combined with Conjugated estrogens.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may decrease the excretion rate of Palonosetron which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), Latamoxef may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), The metabolism of Conjugated estrogens can be increased when combined with Certolizumab pegol.]
[G03CA57, estrogens, conjugated (USP), Eltrombopag may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may decrease the excretion rate of Ammonium chloride which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may increase the thrombogenic activities of Ofatumumab.]
[G03CA57, estrogens, conjugated (USP), The metabolism of Pazopanib can be decreased when combined with Conjugated estrogens.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may decrease the excretion rate of Mycophenolic acid which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), The excretion of Raloxifene can be decreased when combined with Conjugated estrogens.]
[G03CA57, estrogens, conjugated (USP), The serum concentration of Amoxapine can be increased when it is combined with Conjugated estrogens.]
[G03CA57, estrogens, conjugated (USP), The metabolism of Conjugated estrogens can be increased when combined with Fosphenytoin.]
[G03CA57, estrogens, conjugated (USP), The metabolism of Conjugated estrogens can be decreased when combined with Interferon beta-1b.]
[G03CA57, estrogens, conjugated (USP), The metabolism of Conjugated estrogens can be decreased when combined with Interferon beta-1b.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may decrease the excretion rate of Nadolol which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may decrease the excretion rate of Amoxicillin which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), The risk or severity of adverse effects can be increased when Conjugated estrogens is combined with Ropinirole.]
[G03CA57, estrogens, conjugated (USP), The metabolism of Conjugated estrogens can be increased when combined with Nafcillin.]
[G03CA57, estrogens, conjugated (USP), The metabolism of Conjugated estrogens can be decreased when combined with Naloxone.]
[G03CA57, estrogens, conjugated (USP), The metabolism of Conjugated estrogens can be increased when combined with Anakinra.]
[G03CA57, estrogens, conjugated (USP), Amphetamine may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), The metabolism of Naproxen can be decreased when combined with Conjugated estrogens.]
[G03CA57, estrogens, conjugated (USP), The excretion of Conjugated estrogens can be decreased when combined with Troglitazone.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may decrease the excretion rate of Duloxetine which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), The metabolism of Conjugated estrogens can be decreased when combined with Tolcapone.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may decrease the excretion rate of Neomycin which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), The excretion of Repaglinide can be decreased when combined with Conjugated estrogens.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may decrease the excretion rate of Tirofiban which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), Amphotericin B may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may decrease the excretion rate of Ampicillin which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may decrease the excretion rate of Plerixafor which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may decrease the excretion rate of Netilmicin which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), The metabolism of Conjugated estrogens can be decreased when combined with Desvenlafaxine.]
[G03CA57, estrogens, conjugated (USP), Telmisartan may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), The excretion of Valaciclovir can be decreased when combined with Conjugated estrogens.]
[G03CA57, estrogens, conjugated (USP), The excretion of Conjugated estrogens can be decreased when combined with Febuxostat.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may decrease the excretion rate of Amrinone which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), The metabolism of Conjugated estrogens can be decreased when combined with Nicardipine.]
[G03CA57, estrogens, conjugated (USP), The metabolism of Conjugated estrogens can be decreased when combined with Niclosamide.]
[G03CA57, estrogens, conjugated (USP), The metabolism of Nifedipine can be decreased when combined with Conjugated estrogens.]
[G03CA57, estrogens, conjugated (USP), Niflumic acid may increase the thrombogenic activities of Conjugated estrogens.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may decrease the excretion rate of Nisoldipine which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may decrease the excretion rate of Nitric Oxide which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), The therapeutic efficacy of Nitrofurantoin can be decreased when used in combination with Conjugated estrogens.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may decrease the excretion rate of Zaleplon which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may decrease the excretion rate of Pramipexole which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may decrease the excretion rate of Nitroprusside which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), The metabolism of Conjugated estrogens can be decreased when combined with Norfloxacin.]
[G03CA57, estrogens, conjugated (USP), The excretion of Bosentan can be decreased when combined with Conjugated estrogens.]
[G03CA57, estrogens, conjugated (USP), The serum concentration of Nortriptyline can be increased when it is combined with Conjugated estrogens.]
[G03CA57, estrogens, conjugated (USP), The excretion of Conjugated estrogens can be decreased when combined with Novobiocin.]
[G03CA57, estrogens, conjugated (USP), The metabolism of Conjugated estrogens can be decreased when combined with Interferon beta-1a.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may decrease the anticoagulant activities of Reviparin.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may decrease the anticoagulant activities of Reviparin.]
[G03CA57, estrogens, conjugated (USP), The excretion of Conjugated estrogens can be decreased when combined with Nystatin.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may decrease the excretion rate of Clove oil which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), The metabolism of Conjugated estrogens can be increased when combined with Rilonacept.]
[G03CA57, estrogens, conjugated (USP), Omeprazole may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), The serum concentration of Opipramol can be increased when it is combined with Conjugated estrogens.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may decrease the excretion rate of Opium which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may decrease the anticoagulant activities of Reteplase.]
[G03CA57, estrogens, conjugated (USP), The metabolism of Conjugated estrogens can be decreased when combined with Orphenadrine.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may decrease the anticoagulant activities of Ancrod.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may decrease the excretion rate of Tamsulosin which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), The excretion of Conjugated estrogens can be decreased when combined with Ouabain.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may decrease the excretion rate of Oxacillin which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may decrease the excretion rate of Oxazepam which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), Oxyphenbutazone may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), The excretion of Oxytetracycline can be decreased when combined with Conjugated estrogens.]
[G03CA57, estrogens, conjugated (USP), The excretion of Aminohippuric acid can be decreased when combined with Conjugated estrogens.]
[G03CA57, estrogens, conjugated (USP), The metabolism of Asenapine can be decreased when combined with Conjugated estrogens.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may decrease the anticoagulant activities of Danaparoid.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may decrease the excretion rate of Capreomycin which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), The serum concentration of Paramethasone can be increased when it is combined with Conjugated estrogens.]
[G03CA57, estrogens, conjugated (USP), Paromomycin may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), The metabolism of Conjugated estrogens can be decreased when combined with Pefloxacin.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may decrease the excretion rate of Fesoterodine which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may decrease the excretion rate of Penbutolol which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), The excretion of Penicillamine can be decreased when combined with Conjugated estrogens.]
[G03CA57, estrogens, conjugated (USP), The excretion of Benzylpenicillin can be decreased when combined with Conjugated estrogens.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may decrease the excretion rate of Procaine benzylpenicillin which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), Pentamidine may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), The metabolism of Conjugated estrogens can be increased when combined with Pentobarbital.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may decrease the excretion rate of Pentostatin which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), The metabolism of Pentoxifylline can be decreased when combined with Conjugated estrogens.]
[G03CA57, estrogens, conjugated (USP), The excretion of Gadoxetic acid can be decreased when combined with Conjugated estrogens.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may increase the thrombogenic activities of Edrecolomab.]
[G03CA57, estrogens, conjugated (USP), The metabolism of Perphenazine can be decreased when combined with Conjugated estrogens.]
[G03CA57, estrogens, conjugated (USP), The metabolism of Phenacetin can be decreased when combined with Conjugated estrogens.]
[G03CA57, estrogens, conjugated (USP), Phenazopyridine may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may decrease the excretion rate of Phenelzine which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may decrease the anticoagulant activities of Phenindione.]
[G03CA57, estrogens, conjugated (USP), The metabolism of Conjugated estrogens can be increased when combined with Phenobarbital.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may decrease the anticoagulant activities of Phenprocoumon.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may decrease the excretion rate of Phentolamine which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), The excretion of Conjugated estrogens can be decreased when combined with Phenylbutazone.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may decrease the excretion rate of Pentastarch which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), The metabolism of Conjugated estrogens can be increased when combined with Phenylephrine.]
[G03CA57, estrogens, conjugated (USP), The metabolism of Conjugated estrogens can be increased when combined with Phenytoin.]
[G03CA57, estrogens, conjugated (USP), The metabolism of Conjugated estrogens can be increased when combined with Golimumab.]
[G03CA57, estrogens, conjugated (USP), Canrenoic acid may increase the excretion rate of Conjugated estrogens which could result in a lower serum level and potentially a reduction in efficacy.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may decrease the excretion rate of Levofloxacin which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may decrease the excretion rate of Phosphoric acid which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), The excretion of Acamprosate can be decreased when combined with Conjugated estrogens.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may decrease the excretion rate of Phylloquinone which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), Cidofovir may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), The metabolism of Conjugated estrogens can be decreased when combined with Mibefradil.]
[G03CA57, estrogens, conjugated (USP), The metabolism of Pimozide can be decreased when combined with Conjugated estrogens.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may decrease the excretion rate of Pindolol which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), The excretion of Atorvastatin can be decreased when combined with Conjugated estrogens.]
[G03CA57, estrogens, conjugated (USP), The excretion of Piperacillin can be decreased when combined with Conjugated estrogens.]
[G03CA57, estrogens, conjugated (USP), The metabolism of Conjugated estrogens can be decreased when combined with Saquinavir.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may decrease the excretion rate of Piracetam which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), The risk or severity of angioedema can be increased when Conjugated estrogens is combined with Eprosartan.]
[G03CA57, estrogens, conjugated (USP), The excretion of Conjugated estrogens can be decreased when combined with Piroxicam.]
[G03CA57, estrogens, conjugated (USP), The excretion of Conjugated estrogens can be decreased when combined with Piroxicam.]
[G03CA57, estrogens, conjugated (USP), Cefditoren may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), The metabolism of Conjugated estrogens can be decreased when combined with Grepafloxacin.]
[G03CA57, estrogens, conjugated (USP), The metabolism of Conjugated estrogens can be decreased when combined with Delavirdine.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may decrease the anticoagulant activities of Abciximab.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may decrease the anticoagulant activities of Alteplase.]
[G03CA57, estrogens, conjugated (USP), The excretion of Conjugated estrogens can be decreased when combined with Rosiglitazone.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may increase the thrombogenic activities of Ustekinumab.]
[G03CA57, estrogens, conjugated (USP), The therapeutic efficacy of Anastrozole can be decreased when used in combination with Conjugated estrogens.]
[G03CA57, estrogens, conjugated (USP), The metabolism of Conjugated estrogens can be decreased when combined with Alosetron.]
[G03CA57, estrogens, conjugated (USP), The metabolism of Conjugated estrogens can be increased when combined with Canakinumab.]
[G03CA57, estrogens, conjugated (USP), The excretion of Polythiazide can be decreased when combined with Conjugated estrogens.]
[G03CA57, estrogens, conjugated (USP), The serum concentration of Conjugated estrogens can be increased when it is combined with Ritonavir.]
[G03CA57, estrogens, conjugated (USP), The excretion of Saxagliptin can be decreased when combined with Conjugated estrogens.]
[G03CA57, estrogens, conjugated (USP), Potassium may increase the excretion rate of Conjugated estrogens which could result in a lower serum level and potentially a reduction in efficacy.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may decrease the excretion rate of Potassium chloride which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), The therapeutic efficacy of Insulin lispro can be decreased when used in combination with Conjugated estrogens.]
[G03CA57, estrogens, conjugated (USP), The excretion of Pitavastatin can be decreased when combined with Conjugated estrogens.]
[G03CA57, estrogens, conjugated (USP), The metabolism of Praziquantel can be decreased when combined with Conjugated estrogens.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may decrease the excretion rate of Bepotastine which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), The serum concentration of Prednisolone can be increased when it is combined with Conjugated estrogens.]
[G03CA57, estrogens, conjugated (USP), The serum concentration of Prednisone can be increased when it is combined with Conjugated estrogens.]
[G03CA57, estrogens, conjugated (USP), The metabolism of Conjugated estrogens can be decreased when combined with Primaquine.]
[G03CA57, estrogens, conjugated (USP), The metabolism of Conjugated estrogens can be increased when combined with Primidone.]
[G03CA57, estrogens, conjugated (USP), The excretion of Conjugated estrogens can be decreased when combined with Probenecid.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may decrease the excretion rate of Procainamide which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may decrease the excretion rate of Fenofibrate which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), Progesterone may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), The metabolism of Conjugated estrogens can be decreased when combined with Promazine.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may decrease the excretion rate of Promethazine which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), The metabolism of Conjugated estrogens can be decreased when combined with Propafenone.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may decrease the excretion rate of Propantheline which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), The excretion of Fexofenadine can be decreased when combined with Conjugated estrogens.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may decrease the anticoagulant activities of Ardeparin.]
[G03CA57, estrogens, conjugated (USP), The metabolism of Propranolol can be decreased when combined with Conjugated estrogens.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may decrease the excretion rate of Rizatriptan which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may decrease the anticoagulant activities of Epoprostenol.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may decrease the anticoagulant activities of Protein C.]
[G03CA57, estrogens, conjugated (USP), The serum concentration of Protriptyline can be increased when it is combined with Conjugated estrogens.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may decrease the excretion rate of Dalfampridine which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may decrease the excretion rate of Pyrantel which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may decrease the excretion rate of Pyrazinamide which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), Quercetin may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), The metabolism of Conjugated estrogens can be decreased when combined with Quinidine.]
[G03CA57, estrogens, conjugated (USP), The metabolism of Quinine can be decreased when combined with Conjugated estrogens.]
[G03CA57, estrogens, conjugated (USP), The excretion of Conjugated estrogens can be decreased when combined with Acetylsalicylic acid.]
[G03CA57, estrogens, conjugated (USP), The excretion of Ranitidine can be decreased when combined with Conjugated estrogens.]
[G03CA57, estrogens, conjugated (USP), The risk or severity of angioedema can be increased when Conjugated estrogens is combined with Rescinnamine.]
[G03CA57, estrogens, conjugated (USP), The excretion of Conjugated estrogens can be decreased when combined with Reserpine.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may decrease the excretion rate of Ribavirin which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), The metabolism of Conjugated estrogens can be increased when combined with Rifampicin.]
[G03CA57, estrogens, conjugated (USP), The excretion of Conjugated estrogens can be decreased when combined with Roxithromycin.]
[G03CA57, estrogens, conjugated (USP), Salicylamide may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), Sulfasalazine may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), The excretion of Conjugated estrogens can be decreased when combined with Salicylic acid.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may decrease the excretion rate of Secobarbital which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), The metabolism of Selegiline can be decreased when combined with Conjugated estrogens.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may decrease the excretion rate of Selenium which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may increase the thrombogenic activities of Obinutuzumab.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may decrease the excretion rate of Sisomicin which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may decrease the excretion rate of Sodium fluoride which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may increase the thrombogenic activities of Denosumab.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may decrease the excretion rate of Sorbitol which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), The metabolism of Conjugated estrogens can be decreased when combined with Orbifloxacin.]
[G03CA57, estrogens, conjugated (USP), Cabazitaxel may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), Spironolactone may increase the excretion rate of Conjugated estrogens which could result in a lower serum level and potentially a reduction in efficacy.]
[G03CA57, estrogens, conjugated (USP), The excretion of Conjugated estrogens can be decreased when combined with Tacrolimus.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may decrease the excretion rate of Albutrepenonacog alfa which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may decrease the excretion rate of Antihemophilic factor (recombinant), PEGylated which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), The metabolism of Ethanol can be decreased when combined with Conjugated estrogens.]
[G03CA57, estrogens, conjugated (USP), The metabolism of Dasatinib can be decreased when combined with Conjugated estrogens.]
[G03CA57, estrogens, conjugated (USP), The therapeutic efficacy of Hyaluronidase (human recombinant) can be decreased when used in combination with Conjugated estrogens.]
[G03CA57, estrogens, conjugated (USP), The therapeutic efficacy of Hyaluronidase can be decreased when used in combination with Conjugated estrogens.]
[G03CA57, estrogens, conjugated (USP), The therapeutic efficacy of Hyaluronidase can be decreased when used in combination with Conjugated estrogens.]
[G03CA57, estrogens, conjugated (USP), Potassium citrate may increase the excretion rate of Conjugated estrogens which could result in a lower serum level and potentially a reduction in efficacy.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may decrease the excretion rate of Sodium acetate which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may increase the thrombogenic activities of Human immunoglobulin G.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may decrease the excretion rate of Isosorbide mononitrate which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), The therapeutic efficacy of Somatotropin can be decreased when used in combination with Conjugated estrogens.]
[G03CA57, estrogens, conjugated (USP), The metabolism of Conjugated estrogens can be decreased when combined with Levoketoconazole.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may decrease the excretion rate of Azelaic acid which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may decrease the excretion rate of Pentetic acid which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), Tiaprofenic acid may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may decrease the excretion rate of Magnesium chloride which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may decrease the excretion rate of Megestrol acetate which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may decrease the excretion rate of Methyldopa which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), The metabolism of Conjugated estrogens can be increased when combined with Methylene blue.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may decrease the anticoagulant activities of Tinzaparin.]
[G03CA57, estrogens, conjugated (USP), The excretion of Conjugated estrogens can be decreased when combined with Benzoic acid.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may decrease the excretion rate of Amoxicillin which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), Amphotericin B may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may decrease the excretion rate of Ampicillin which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), The therapeutic efficacy of Nitrofurantoin can be decreased when used in combination with Conjugated estrogens.]
[G03CA57, estrogens, conjugated (USP), The excretion of Bosentan can be decreased when combined with Conjugated estrogens.]
[G03CA57, estrogens, conjugated (USP), The excretion of Oxytetracycline can be decreased when combined with Conjugated estrogens.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may decrease the excretion rate of Levofloxacin which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), Cidofovir may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), The excretion of Piperacillin can be decreased when combined with Conjugated estrogens.]
[G03CA57, estrogens, conjugated (USP), The excretion of Saxagliptin can be decreased when combined with Conjugated estrogens.]
[G03CA57, estrogens, conjugated (USP), The therapeutic efficacy of Insulin lispro can be decreased when used in combination with Conjugated estrogens.]
[G03CA57, estrogens, conjugated (USP), The excretion of Prednisolone phosphate can be decreased when combined with Conjugated estrogens.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may decrease the excretion rate of Fenofibric acid which could result in a higher serum level.]
